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ABSTRACT
Attention-Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder
characterized by symptoms of inattention and/or a combination of hyperactivity and
impulsivity. Motor problems, including poor graphomotor skills, are frequently found in
those with ADHD and have been noted to be undertreated. Variability of performance
within several domains has also been indicated as a hallmark of ADHD. The present
study sought to 1) determine whether the variability of performance observed in other
psychological domains in those diagnosed with ADHD manifests within kinematic
variables of graphomotor output and 2) determine whether a novel writing task
differentially affects the graphomotor output of adults diagnosed with ADHD versus
controls. Findings and implications are discussed.
Keywords: digitizing tablet, stimulant medication, fine motor skills,
variability of task performance
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CHAPTER I
INTRODUCTION
Attention-Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental
disorder characterized primarily by symptoms of inattention and/or a combination of
hyperactivity and impulsivity (Barkley, 2006). In addition to the diagnostic criteria that
define ADHD, several other impairments have been consistently identified in those with
ADHD. These characteristics include motor skill impairments, such as poor handwriting,
and variability of task performance, which manifests within several domains. One
promising method that has been used to investigate graphomotor functioning (i.e.,
handwriting) is kinematic analysis, which has historically involved the use of digitizing
technology. Kinematic analysis of graphomotor functioning in the ADHD population has
indicated that within the context of medication status (i.e., whether taking prescribed
dosages of stimulant medication or having discontinued medication), children with
ADHD differ in automatized graphomotor fluency when compared to unaffected
children. Similar results have not been documented in adults with ADHD. However, no
study has investigated whether the variability of performance that is observed within the
ADHD population extends into the graphomotor domain.
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CHAPTER II
REVIEW OF LITERATURE
Diagnostic Criteria
The most recent version of the Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV-TR; American Psychiatric Association, 2000) estimates the
prevalence of ADHD to be between 3% and 7% of school aged children in the United
States. In adults, the prevalence of ADHD has been estimated at approximately 4% (as
cited in Biederman, 2005). Data demonstrating persistence of ADHD symptomatology
from childhood into adulthood are mixed, with estimates ranging between 4%
(Mannuzza, Klein, Bessler, Malloy, & LaPadula, 1998) and 85% (Barkley, Fischer,
Smallish, & Fletcher, 2002). Although estimations may be conservative in general (Root
& Resnick, 2003), Barkley (2006) has indicated that prevalence estimates of ADHD
differs based on a variety of factors, including sex, age, diagnostic criteria, data collection
methods, and country of origin.
Utilizing criteria described in the DSM-IV-TR, a diagnosis of ADHD can be
given to those who demonstrate either “six (or more)” symptoms of inattention and/or
“six (or more)” symptoms related to hyperactivity and impulsivity that “have persisted
for at least 6 months to a degree that is maladaptive and inconsistent with developmental
level” (American Psychiatric Association, 2000, p. 92). Further, these symptoms must
have been observed before the individual was 7 years old and with impairment occurring
in two or more settings (e.g., at school, in the home, and/or in the work-place). Specific
subtypes of ADHD, which correspond to different combinations of symptomatology,
include ADHD combined type (ADHD-C), ADHD Predominantly Inattentive Type
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(ADHD-PI), and ADHD Predominantly Hyperactive-Impulsive Type (ADHD-HI). A
diagnosis of ADHD-C requires that both six or more symptoms of inattention and six or
more symptoms of hyperactivity-impulsivity have been present for at least the past six
months. The ADHD-PI subtype is indicated when six or more symptoms of inattention
are present for at least six months, but fewer than six symptoms of hyperactivityimpulsivity are present during this same time period. Finally, a diagnosis of ADHD-HI is
appropriate if six or more symptoms related to hyperactivity-impulsivity have been
present for at least the past six months, but fewer than six symptoms of inattention are
present during this same time period.
Etiology of ADHD
The etiology of ADHD is complex in nature, although recent research implicates
neurological and genetic factors as primary agents of pathogenesis (Barkley, 2006). The
advent and subsequent popularity of modern neuroimaging techniques such as magnetic
resonance imaging (MRI) and diffusion tensor imaging (DTI) have enhanced the ability
of researchers to analyze the structural neuroanatomy of individuals in a non-invasive
manner. In the case of ADHD, several consistent findings have emerged with regard to
abnormal structure of the central nervous system (Barkley, 2006). Widespread
reductions of cortical gray matter have been found in the frontal, parietal, temporal, and
occipital lobes of the cerebral cortex in general (Batty et al., 2010; Shaw et al., 2006) and
in frontal and posterior association cortices in particular (Narr et al., 2009). Although
findings vary to some degree between studies, reductions in gray matter volume have
been found in more circumscribed areas of the cortex and subcortical nuclei in both
children and adults with ADHD. These areas include the prefrontal and dorsolateral
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prefrontal cortices, basal ganglia (caudate nucleus, globus pallidus, putamen, and
substantia nigra), and anterior cingulate cortex (Amico, Stauber, Koutsouleris, & Frodl,
2010; Castellanos, Geidd, Marsh, & Hamburger, 1996; McAlonan et al., 2007; Romanos
et al., 2010; Seidman et al., 2011). Reductions in the infratentorial structural volume of
the cerebellar vermis have also been found in both children (Castellanos et al., 2001;
Durston et al., 2004; Mackie et al., 2007) and adults (Seidman et al., 2011) diagnosed
with ADHD.
Research also indicates that although those diagnosed with ADHD do not
consistently demonstrate global reductions in white matter volume compared to controls
(Amico et al., 2010; Batty et al., 2010; Durston et al., 2004; McAlonan et al., 2007; Narr
et al., 2009), reduced white matter volumes in specific areas of the cerebrum have been
more consistently documented. For example, McAlonan et al. (2007) found that white
matter tracts of the corpus callosum evidenced reduced volume in those diagnosed with
ADHD. This finding is consistent with past studies indicating reduction in white matter
of the corpus callosum in general (Hynd et al., 1991) and the splenium of the corpus
callosum in particular (Semrud-Clikeman et al., 1994). Other studies investigating the
structural integrity of white matter pathways connecting different regions of the cerebrum
suggest that these pathways appear to be compromised in the ADHD population (Konrad
& Eickhoff, 2010). More specifically, the superior longitudinal fasciculus and anterior
corona radiata, which are tracts projecting between the frontal cortex and basal ganglia,
have evinced reduced white matter integrity in children and adults based on
measurements of fractional anisotropy (FA; representing the directionality and shape of
the water molecules within the tract), mean diffusivity (MD), and apparent diffusion
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coefficient (ADC; representing the volume of white matter diffusion) (Liston, Cohen,
Teslovich, Levenson, & Casey, 2011). Due to the aforementioned inconsistencies in
white matter volumetric findings in the ADHD literature, however, firm conclusions
concerning the role of white matter pathways in the pathophysiology of ADHD cannot be
drawn at this time.
Although relationships between ADHD symptomatology and structural
abnormalities can only be inferred due to the nature of these studies, functional
neuroimaging techniques, such as functional magnetic resonance imaging (fMRI),
provide additional evidence that structures believed to subserve abilities related to
attention, inhibition, and motor control – abilities that are impaired in those with ADHD
– are the same structures that demonstrate structural abnormalities in ADHD (BrossardRacine, Majnemer, & Shevell, 2011; Seidman et al., 2006; Swanson, Castellanos, Murias,
LaHoste, & Kennedy, 1998; Shaw et al., 2006). Compared with healthy children,
children with ADHD show abnormal patterns of activation (i.e., hypo-activation) in the
prefrontal cortex, basal ganglia, and cerebellum when performing tasks related to
attention, inhibition, motor control, and executive function (Bush et al., 1999; Durston et
al., 2003; Posner et al., 2011; Rubia et al., 1999; Teicher et al., 2000; Vaidya et al., 1998;
Yeo et al., 2003). Differences also appear to persist into adulthood. For example,
Cubillo, Halari, Giampietro, Taylor, & Rubia (2011) found that compared with
neurotypical individuals, medication naive adults diagnosed with ADHD in childhood
who continued to demonstrate symptomatology into adulthood were found to have
reduced activation in the orbital frontal cortex, medial frontal cortex, and striatum (i.e.,
basal ganglia) during tasks requiring inhibition, as well as reduced activation in the lateral
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inferior and dorsolateral prefrontal cortices during tasks of working memory and
attention.
Although studies have not demonstrated that ADHD occurs as a result of
chromosomal abnormalities, several lines of research (i.e., family, adoption, twin, and
genetic studies) indicate that ADHD has a high degree of heritability (Barkley, 2006).
Highlighting the heritable and familial nature of ADHD – with some heritability rates
estimated to be as high 0.76 (Faraone et al., 2005) – are findings that asymptomatic
siblings of those diagnosed with ADHD demonstrate a trend towards similar volumetric
reductions in cortical regions comparable with those found in their affected siblings
(Durston et al., 2004).
At least seven genes appear to be implicated in the etiology of ADHD (Faraone et
al., 2005), although several other genes are currently under investigation (see
Banaschewski, Becker, Scherag, Franke, & Coghill, 2010, for a review). One example is
the dopamine transporter gene, DAT1, which has received significant attention as
mutations of this gene have been found to be related to presence of ADHD
symptomatology in both adults (Brown et al., 2011) and children (Daly, Hawi, Fitzgerald,
& Gill, 1999).
Dysfunction or imbalance of dopamine (DA), norepinephrine (NE), and
noradrenaline (NA) neurotransmitters have also been implicated in the pathophysiology
of ADHD (Arnsten, Berridge, & McCracken, 2009; Barkley, 2006; Biderman, 2005). In
a recent review of the literature investigating the influences of DA and NA in ADHD, del
Campo, Chamberlain, Sahakian, and Robbins (2011) suggested that DA and NA may
play more specific roles in the presentation of ADHD symptomatology. That is, whereas
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a combination of DA and NA abnormalities may affect functioning of the prefrontal
cortex and by extension abilities related to inhibition, DA alone may affect functioning of
subcortical structures such as the basal ganglia, in turn affecting attentional abilities.
Impairments Associated with ADHD
Beyond the primary symptoms of inattention, hyperactivity, and impulsivity,
decades of research has demonstrated that ADHD is associated with numerous
impairments affecting various domains of activities and functioning. Areas of
impairment include cognitive functioning, language development and expression, motor
skills, emotional regulation, academic performance, consistency of task performance, and
general health and well-being (Barkley, 2006). Of particular interest here are the motor
control problems, which are often under-treated in this population (Fliers et al., 2009),
and the variability of task performance and expression.
Individuals diagnosed with ADHD have been shown to demonstrate variability in
task performance and behaviours within several domains, including emotional expression
(i.e., emotional lability; Barkley & Fischer, 2010; Posner et al., 2011), qualitative and
quantitative handwriting production (Rosenblum, Epsztein, & Josman, 2008), in-phase
bimanual coordination (Klimkeit, Sheppard, Lee, & Bradshaw, 2004), motor force output
(Pereira, Eliasson, & Forssberg, 2000), and fine motor skill movements (Pitcher, Piek, &
Barrett, 2002). Anecdotal reports from teachers and parents also suggest that children
diagnosed with ADHD, as compared to healthy children, display a great deal of
variability in their academic work and the quality with which they complete household
duties (Barkley, 2006). Due to the observation that variability of task performance has
been documented in several domains and appears to be ubiquitous in this population,
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“some believe [variability of task performance] to be a primary deficit in ADHD”
(Barkley, 2006, p. 136).
Although it is still unclear whether or not developmental motor milestones are
generally delayed in children with ADHD (Barkley, 2006), the pervasive nature of motor
difficulties that are observed in this population is highlighted by findings demonstrating
significant comorbidity with Developmental Coordination Disorder, which is
characterized by “marked impairment in the development of motor coordination” that
“significantly interferes with academic achievement or activities of daily living”
(American Psychiatric Association, 2000, pp. 56-57), when compared to the general
population (Kadesjo & Gillberg, 2001; Piek, Pitcher, & Hay, 1999). Indeed, there is
some evidence to suggest that ADHD and Developmental Coordination Disorder (DCD)
share a genetic component (Martin, Piek, & Hay, 2006). Regardless of the presence of
DCD, it is clear that those diagnosed with ADHD demonstrate motor impairments more
frequently than the general population (Brossard-Racine, Majnemer, & Shevell., 2011).
Examples of motor impairments found in those diagnosed with ADHD include poor
handwriting (Brossard-Racine, Majnemer, Shevell, Snider, & Belanger, 2011); decreased
speed and accuracy of complex (but not simple) fine and tactual motor performance
(Meyer & Sagvolden, 2006); and deficits in balance, manual dexterity, coordination, and
fine and gross motor skills (Piek, Pitcher, & Hay, 1999). Highlighting the importance of
impairments in both motor functioning in general and timing of motor behaviour in
particular are studies indicating that these problems are not only found in those diagnosed
with ADHD, but also in siblings without an ADHD diagnosis. For example, Rommelse
and colleagues (2008) found this relationship between affected and non-ADHD siblings
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and concluded that based on the evidence, “Variability in motor timing appears a useful
endophenotypic candidate: It is clearly associated with ADHD, it is also present in nonADHD siblings, and it correlates within families” (p. 131). “Moderate” and statistically
significant positive correlations between severity of ADHD symptomatology and severity
of motor sequelae have also been documented (Rommelse et al., 2009), which provide
additional support for the notion that both motor control dysfunction and variability in
task performance could be considered as primary deficits in those diagnosed with ADHD.
Relevant to the academic success of children is the skill of handwriting. In a
review of the literature investigating the handwriting skills of children diagnosed with
ADHD, Brossard-Racine, Majnemer, Shevell, and Snider (2008) concluded that the
handwriting of individuals in this population can be characterized as impaired, often
illegible, and less organized than the handwriting of control children, which in turn
results in low academic achievement. Poor qualitative writing observed in this
population does not appear to be related to pure visual-perceptual, visual-motor
integration, or linguistic difficulties; instead, poor performance likely involves many
different processes (Brossard-Racine et al., 2008), including dysfunction in basic
parameter setting, such as regulation of force, speed, and size of graphomotor movements
(van Galen, 1991); motor control; and timing aspects of handwriting (Adi-Japha et al.,
2007; Marcotte & Stern, 1997; Schoemaker, Ketelaars, van Zonneveld, Minderaa, &
Mulder, 2005).
Kinematic Analysis of Handwriting
The volitional control of handwriting can be thought of as a complex process
involving the integration of “cognitive, psychomotor, and biophysical processes” (van
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Galen, 1991, p. 165) that are organized hierarchically and in parallel (Plamondon, 1995a)
to produce meaningful visual-spatial output. Using a motor program metaphor,
graphomotor processes begin with the retrieval of a high-level representation of the
desired motor output - which might involve acquiring trajectory based stroke segments
that can be combined to form complex symbols as opposed to retrieving whole letters or
words stored within a visual-spatial “brain dictionary” (Lacquaniti, 1989, p. 287). This in
turn is followed by a conversion of this representation into motor control “commands,”
finally ending with the neuromuscular system responding in the desired manner
(Plamondon, Yu, Stelmach, & Clement, 1991). In addition, the neuromuscular and
higher-order systems make necessary adjustments based on relevant “visual and/or
kinesthetic feedback” (Dooijes, 1983, p. 104). Central nervous system structures likely
involved in these motor output processes include the primary motor cortex, premotor
cortex, supplemental motor area, basal ganglia, cerebellum, and spinal cord (Plamondon,
1995a).
Studies investigating the cognitive, psychomotor, and biophysical processes
involved in graphomotor control generally support this process and its related
components (Meulenbroek & Thomassen, 1993; Meulenbroek & van Galen, 1988;
Portier & van Galen, 1992; Teulings, Thomassen, & van Galen, 1983; van Galen, 1990;
Woch, Plamondon, & O’Reilly, 2011; see Plamondon & Maarse, 1989, for a review and
evaluation of computational motor models of handwriting), with the initial phases of
voluntary motor control represented by measurements of reaction time and the latter
phases represented by measurements of total movement time (Bellgrove et al., 1997) and
other variables. The use of objective tools and methods to assess handwriting movements
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(e.g., kinematic analysis), then, can be viewed as a method to make inferences about
these cognitive, psychomotor, and biophysical processes underlying graphomotor
function.
Kinematic analysis involves the quantification of “time changes of position,
velocity, and acceleration” (Viviani & Terzuolo, 1982, p. 431). Although many
technological options are available for kinematic analysis, the use of digitizing tablets to
capture handwriting signals has predominated in graphonomic research of both healthy
and clinical populations over the past 30 years (for a review of early graphomotor
research, including the use of digitizing tablets, see Graham & Weintraub, 1996). In the
domain of graphonomics, kinematic measures can be quantified using parameters of time,
acceleration, velocity, and pen pressure, and variables derived from these basic measures
can be used to (a) describe abilities related to degree of movement automatization and
fluency (Eichhorn et al., 1996; Margolin & Wing, 1983; Mergl, Tigges, Schroter, Moller,
& Hegerl, 1999; Portier & van Galen, 1992; Teulings, Contreras-Vidal, Stelmach, &
Adler, 1997; Yan, Rountree, Massman, Doody, & Li, 2008); (b) quantify the relative
decelerations and accelerations of handwriting movements (Eichhorn et al., 1996; Mergl
et al., 1999; Plamondon & Clement, 1991; van Galen, Portier, Smits-Engelsman, &
Schomaker, 1993); (c) indicate stability, coordination, and consistency of an individual’s
handwriting (Mergl et al., 1999; Schroter et al., 2003; Teulings & Schomaker, 1993;
Slavin, Phillips, Bradshaw, Hall, & Presnell, 1999); (d) indicate the sharing of processing
resources, the difficulty of writing trajectories, and the presence of dysmetria (van Galen,
1991; Teulings, Contreras-Vidal, Stelmach, & Adler, 1997; Phillips et al., 2009); (e)
quantify fine motor hypotonia and general proficiency (Mergl et al., 1999; Wann &
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Nimmo-Smith, 1991; Phillips et al., 1999); and (f) indicate the smoothness and efficiency
of movements (Bellgrove et al., 1997; Phillips et al., 2009). In this sense, the metrics
produced by kinematic analyses of handwriting can be viewed as objective rather than
subjective measurements of graphomotor performance.
Clinical Research Utilizing Kinematic Analysis
The use of digitizing technology to quantify graphomotor processes as an
investigative and potentially diagnostic tool has been conducted with a multitude of
patient populations. Pathologies and disorders investigated include, but are not limited
to, ADHD (e.g., Adi-Japha et al., 2007; Flapper, Houwen, & Schoemaker, 2006;
Schoemaker et al., 2005; Tucha & Lange, 2001, 2004, 2005; Tucha, Paul, & Lange,
2003); Dementia, Alzheimer’s Disease, and Mild Cognitive Impairment (e.g., Bellgrove
et al., 1997; Yan et al., 2008); DCD (e.g., Bo, Bastien, Kagerer, Contreras-Vidal, &
Clark, 2008; Chang & Yu, 2010; Rosenblum & Livneh-Zirinski, 2008; Smits-Engelsman
Niemeijer, & van Galen, 2001); Dysgraphia (e.g., Kushki, Schwellnus, Ilyas, & Chau,
2011; Overvelde & Hulstijn, in press; Rosenblum, Dvorkin, & Weiss, 2006; SmitsEngelsman & van Galen, 1997); Huntington’s Disease (e.g., Phillips et al., 1996; Phillips,
Chiu, Bradshaw, & Iansek, 1995; Slavin et al., 1999; Yaguez, Canavan, Lange, &
Homberg, 1999); Learning Disability (e.g., Galli et al., 2011; van Roon, Caeyenberghs,
Swinnen, & Smits-Engelsman, 2010); Schizophrenia (e.g., Grootens et al., 2009; Jahn et
al., 2006; Putzhammer et al., 2005; Tigges et al., 2000); and Parkinson’s Disease (e.g.,
Gangadhar et al., 2009; Poluha, Teulings, & Brookshire, 1998; Ponsen et al., 2006; Rand,
Stelmach, & Bloedel, 2000; van Gemmert, Teulings, & Stelmach, 1998). Germane to the
present study are findings related to ADHD.
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Using qualitative variables such as legibility; spacing, letter size, and alignment
consistency; organization of material within space; and letter insertions, transpositions,
substitutions, and omissions, studies of handwriting produced by children diagnosed with
ADHD indicate that their writing quality is generally poor, immature, and error-prone
when compared with non-ADHD controls (Adi-Japha et al., 2007; Flapper et al., 2006;
Lerer, Artner, & Lerer, 1979; Marcotte & Stern, 1997; Whalen, Henker, & Finck, 1981;
Tucha & Lange, 2001). In addition, poor qualitative performance does not appear to be
the result of purely linguistic, visual, perceptual, or visual motor integration deficits (AdiJapha et al., 2007; Marcotte & Stern, 1997) and typically improves after taking prescribed
dosages of stimulant medication (Lerer et al., 1979; Tucha & Lange, 2001; Whalen et al.,
1981). Interestingly, kinematic analyses assessing objective, process related aspects of
handwriting indicate that the handwriting produced by children diagnosed with ADHD is
more dysfluent and thus appears less automatized when taking stimulant medication
compared to when they are not taking prescribed medication, and is more dysfluent when
such children are on stimulant medication than observed in controls (Flapper et al., 2006;
Tucha & Lange, 2001, 2004, 2005). This pattern of fluency and dysfluency related to
medication status, however, has not been observed in adults diagnosed with ADHD under
similar conditions (Tucha & Lange, 2004). In these contexts, writing fluency is
operationalized as the number of changes in direction of velocity or acceleration as
recorded by digitizing technology and analyzed by appropriate software. Velocity
profiles of fluent, automatized handwriting appear as smooth asymmetrical bell-shaped
curves with few changes in velocity/acceleration direction, whereas dysfluent,
unautomatized handwriting evinces velocity profiles with multiple “jagged peaks” and
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many changes in the direction of velocity/acceleration. See Figures 1 and 2 for examples
of fluent versus dysfluent vertical velocity profiles, respectively.

Figure 1. Velocity profile of the word “hello” written fluently.
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Figure 2. Velocity profile of the word “hello” written with simulated dysfluency.
In addition, these studies demonstrated that while off prescribed dosages of stimulant
medication, kinematic measures of graphomotor fluency in affected children were not
significantly different from those of non-ADHD controls. Further, it does not appear that
these findings are due to a direct effect of medication, as fluent movements can be
elicited from children with ADHD taking stimulant medication (Tucha & Lange, 2004).
Rather, this decreased fluency and automaticity may be the result of a secondary effect
resulting from enhanced attention, from greater cognitive control (Tucha & Lange, 2004;
Tucha, Mecklinger, Walitza, & Lange, 2006; Tucha et al., 2003), or from possibly other
cognitive, motor, or psychomotor processes influenced by stimulant medication.
Alternatively, Lange et al. (2007) suggested that children and adults with ADHD may, in
general, “have difficulties in skills whose acquisition starts as a [laboured] and conscious
learning process that becomes automatic following consistent and frequent practice” (p.
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256). Similarly, Flapper et al. (2006) noted that typically, accuracy is achieved before
speed and fluency when learning a complex task. In turn, children with ADHD would
first need to engage sufficient attentional resources and motor skills for an extended
period of time before generating handwriting that is both fluent and accurate, noting that
both attentional abilities and motor skills are reported to improve with methylphenidate
treatment in adults, adolescents, and children diagnosed with ADHD (Bart, Podoly, &
Bar-Haim, 2010; Lerer et al., 1979; Shafritz, Marchione, Gore, Shaywitz, & Shaywitz,
2004; Stray, Stray, Iverson, Ruud, & Ellersten, 2009; Tucha, Mecklinger, Laufkotter, et
al., 2006; Tucha, Prell, et al., 2006).
The Present Study
There are few studies that have investigated the kinematic aspects of writing in
adults diagnosed with ADHD, with no study specifically examining the potential
variability of task performance within the kinematic aspects of graphomotor skills in
adults diagnosed with ADHD, and no study comparing novel versus putatively
automatized graphomotor processes in this population. As such, using a digitizing tablet
to capture kinematic aspects of handwriting, the present study seeks to determine within
the context of medication status 1) whether the variability of performance observed in
other psychological domains (e.g., task persistence, emotion, and attention) in those
diagnosed with ADHD manifests within kinematic variables associated with consistency,
stability, and coordination during the execution of an automatized graphomotor task; and
2) assess the effects of novelty on consistency measures of graphomotor performance
between adults with and without ADHD. Under the premise that handwriting output is
generated from a velocity control perspective (i.e., that the central nervous system
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produces volitional graphomotor output by controlling the velocity of an end-effector via
interactions between higher-order cortical and sub-cortical systems and lower-level
agonist and antagonist neuromuscular systems [Guerfali & Plamondon, 1997;
Plamondon, 1993, 1995a, 1995b, 1998; Plamondon, Feng, & Woch, 2003]) and noting
variability of performance/behaviour demonstrated in other psychological domains in
those diagnosed with ADHD, it is hypothesized that 1) greater intra-individual variability
in kinematic velocity measures will be observed in adults diagnosed with ADHD off
medication when compared to neurotypical adults. Additionally, 2) although no a priori
hypothesis is salient with regard to the effects of novelty on variability measures in those
diagnosed with ADHD, it could be speculated that if variability of performance observed
in adults with ADHD extends to the graphomotor domain, ADHD participants
discontinuing medication will be differentially affected by a novel graphomotor task and
in turn elicit greater levels of inconsistency compared to those without ADHD. Should
statistically and practically significant differences become evident (i.e., differences of
medium to large effect sizes), this would be the first study utilizing kinematic analysis to
explicitly demonstrate variability of performance within the graphomotor domain in
adults diagnosed with ADHD. Significant results indicating variability in kinematic
performance would also add to the current literature indicating that ADHD is not simply
a disorder of childhood, but rather, a disorder in which specific motor control differences
extend into adulthood. Further, the results of this study would support conducting future
research into the use of digitizing technology as an objective diagnostic and descriptive
tool within the ADHD population, which in turn may enhance the specificity and/or
sensitivity of current assessment and diagnostic techniques.

17

CHAPTER III
DESIGN AND METHODOLOGY
Participants
Power analysis (α = .05, [1 – β] = .80) indicated that using the proposed
methodological design and statistical analysis, 52 total participants would be needed to
detect a statistically significant difference of large effect size. For within-group
differences, power analysis indicated that 16 participants would be needed to detect
differences of large effect size.
Thirty-eight participants were recruited through three sources: control
participants were recruited via the University of Windsor’s Psychology Participant Pool
(n = 31) and clinical participants were recruited through Student Disabilities Services
(Education Development Center) at the University of Windsor and through the private
practice of a local psychiatrist (n = 8). One control participant, however, requested that
their data be removed from the study, resulting in a net of 30 control participants and 38
total participants. To minimize confounds related to extraneous visual and motor
disturbances, participants included only those with normal or corrected to normal vision
and those who did not have an existing neurological condition that would negatively
affect graphomotor performance (e.g., cerebral palsy affecting the upper extremities,
severe tendinitis, or carpal tunnel syndrome). In addition, clinical participants included
only those who were currently taking prescribed dosages of stimulant medication for the
treatment of ADHD symptoms. Participants recruited through the University of
Windsor’s Psychology Participant Pool received course bonus points (1 point for control
participants based on one hour of participation time and 2 bonus points for clinical
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participants based on two hours of participation time) for participating in the research
study. Participants recruited through Student Disability Services at the University of
Windsor and the private practice of the local psychiatrist received a $10 gift card and a
chance to win one of two $50 debit cards via entry into a draw.
Materials and Apparatus
Demographic information and ADHD symptomatology. For the purposes of
sample description, participant demographic information including age, sex, handedness,
current medications (including type and dosage), ethnicity, official ADHD diagnosis and
subtype (if applicable), and neurological status was collected from each participant via an
in-person interview (see Appendix A for the interview form used). For participants
diagnosed with ADHD, records pertaining to official diagnoses were reviewed and
specific diagnoses if available (e.g., ADHD-C, ADHD-PI, ADHD-HI, and any comorbid
diagnoses) were also recorded for descriptive purposes. In addition, all participants
completed the Barkley Adult ADHD Rating Scale-IV (BAARS-IV; Barkley, 2011).
Based on DSM-IV diagnostic criteria, the BAARS-IV is a self-report questionnaire
designed to evaluate current and/or childhood ADHD symptoms in adults between the
ages of 18 and 81 years. According to the manual, the normative sample used to develop
the BAARS-IV, which consisted of 1,249 adults between the ages of 18 and 96, “closely
approximated the U.S. adult population based on the U.S. Census from the year 2000
concerning regional distribution, sex, race/ethnic group, marital status, employment
status, total household income, and education” (Barkley, 2011, p. 14). After completion
of the questionnaire, a total ADHD score, symptom count, and subscale scores for both
current symptoms and childhood symptoms can be calculated. (Note: the BAARS-IV

19

20

also contains forms allowing current and childhood symptomatology scores to be derived
based on reports from others through the use of an alternative quick-screen. These were
not utilized in this study). The BAARS-IV also produces subscale scores related to four
recognized ADHD symptom dimensions: Inattention, Hyperactivity, Impulsivity, and
Sluggish Cognitive Tempo (SCT). According to the BAARS-IV manual, ADHD scores
at or above the 93rd percentile may be interpreted as reflecting a significant abnormality
and clinical significance in that domain. Because clinical participants participated in the
research both on and off of their ADHD medication, they were asked to answer the
questionnaire regarding their current symptomatology within the context of being off of
their medication. Finally, if subtype identifier information was unavailable or unknown,
a determination of subtype was made based upon the clinical participant’s self-report
current ADHD symptoms as measured by the BAARS-IV. That is, for clinical
participants only, a subtype identifier of ADHD-PI was given if significant abnormality
was reported only within the Inattention domain, a subtype identifier of ADHD-HI was
given if significant abnormality was reported only within the Hyperactivity or
Impulsivity domains, and a subtype identifier of ADHD-C was given if significant
abnormality was reported within both the Inattention domain and the Hyperactivity or
Impulsivity domains.
Internal consistency reliability of the BAARS-IV was reported by the manual to
be “satisfactory” for current symptom total score and for each subscale/domain score for
both current and childhood reported symptoms. Test-retest reliability was described as
“reasonable” over a 2- to 3-week period. Finally, construct validity, discriminant
validity, and criterion validity are reported to be “satisfactory.” Internal consistency and
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test-retest reliability measures for the BAARS-IV, as indicated by the manual (Barkley,
2011), are listed in Table 1.
Table 1
Internal Consistency & Test-Retest Reliabilities of the BAARS-IV*

ADHD Inattention

Internal Consistency
Reliability
Current
Childhood
Symptoms
Symptoms
.902
.940

Current
Symptoms
.66

Childhood
Symptoms
.73

.912†

.72

.82†

ADHD Hyperactivity

.776

ADHD Impulsivity

.807

Total Score

.914

Test-Retest Reliability**

.76
.947

.75

.79

Note. * Barkley Adult ADHD Rating Scale-IV. ** Test-retest reliability over a 2- to
3-week period. † Represents combined dimension of hyperactivity-impulsivity.
Estimate of intellectual ability. An estimate of IQ was derived using four
subtests of the Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV; Wechsler,
2008). Based on practical considerations and the best combination of short form
reliability and validity coefficients (.953 and .940, respectively; see Sattler & Ryan,
2009), the four subtests used for estimating IQ were Block Design (BD), Vocabulary
(VC), Arithmetic (AR), and Coding (CD). IQ estimates were used for descriptive
purposes and for identifying initial group differences between the control group and the
clinical group.
Kinematic analysis and digitizing tablet. A WACOM Cintiq 21UX digitizing
tablet was used to record the handwriting movements of participants. The digitizing
tablet has an active display area of 17” by 12.75” and spatial resolution of 5080 lines per
inch. Because this tablet provides real-time on-screen visual feedback, a special non-
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inking pen was used by participants. MovAlyzeR software (NeuroScript, LLC; Tempe,
AZ, USA) was utilized to quantify handwriting movements with a maximum sampling
rate of 200 Hz and x-y coordinates were low-pass filtered at 12 Hz. Handwriting
movements were broken down by MovAlyzeR software into strokes using interpolated
vertical velocity zero crossings. In this sense, a stroke, representing a “unit” of
handwriting, can be defined as “a segment bounded by time moments at which the
vertical component of the velocity changes sign” (Teulings, Thomassen, & van Galen,
1983, p. 168).
Kinematic variables derived using MovAlyzeR software include Relative intraindividual standard deviation of Peak Velocity (RPV) and Normalized Jerk (NJ). The
RPV variable is a coefficient of variation (CV) that was derived by dividing the absolute
standard deviation of mean peak velocity of each digitized word or symbol by the
average peak velocity of the digitized word or symbol (Mergl et al., 1999). The word
“hello” and the novel symbol “

” are described below (see Figure B1 in Appendix B

for a scaled version of the novel symbol). The RPV variable reflects stability,
coordination, and consistency of an individual’s handwriting, with less consistently
controlled movements indicated by higher values and more consistently controlled
movements reflected by lower values (Mergl et al., 1999; Schroter et al., 2003). An RPV
value of 0 would indicate completely identical mean peak velocity across all trials of a
writing task.
NJ is a measure of writing smoothness and fluency. High NJ scores indicate
dysfluent movement and low NJ scores indicate smoother, fluent, and more automatized
movement (Teulings et al., 1997; Yan et al., 2008). Said another way, as one practices
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and in turn automatizes a graphomotor program, dysfluency decreases (Portier & van
Galen, 1992), as will the NJ variable. In turn, the NJ measure should indicate greater
dysfluency when individuals write a novel symbol or grapheme on the digitizing tablet
versus a well-practiced and automatized symbol or grapheme. The NJ variable is similar
to the dysfluency measure of “number of inversions of acceleration” used in much of the
research utilizing kinematics to investigate graphomotor problems in those diagnosed
with ADHD (for examples, see Flapper et al., 2006; Schoemaker et al., 2005; Tucha &
Lange, 2001, 2004, 2005; Tucha et al., 2006; and Tucha et al., 2003) in that NJ “is the
change of acceleration per time” (Teulings et al., 1997, p. 160). NJ, however, has the
advantage of allowing the comparison of words or symbols of varying size and
movement durations because it is normalized (Teulings et al., 1997).
All demographic and research data were kept confidential and secure.
Additionally, participant demographic and research data were de-identified (i.e., coded
with a randomly assigned participant identification number) but still attached to
identifying information for two weeks after the data were collected, thus giving
participants the opportunity to withdraw their data from the study. After this time, the
link connecting identifying personal information with demographic and research data was
removed and only arbitrary participant identification numbers were associated with
demographic and research data.
Procedures
In the following order, participants: 1) took part in an interview with the
researcher to provide demographic and medical information, 2) answered questions
related to ADHD symptomatology, 3) participated in an abbreviated test of general
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intellectual ability, 4) signed their name on the digitizing tablet 10 times, 5) wrote the
word “hello” in lower-case using cursive handwriting on the digitizing tablet 30 times
(representing the automatized condition), and 6) wrote the novel symbol “

” on the

digitizing tablet 30 times (representing the novel word condition). A sample of this word
and symbol was visible to the participant on a card throughout the graphomotor task.
Instructions for all tasks were given aurally, with instruction provided visually on the
digitizing tablet throughout.
All data from control participants was collected in one session. Data obtained
from clinical participants was collected on two occasions, once while the participants
were taking prescribed dosages of ADHD medication and a second time after abstaining
from prescribed dosages of ADHD medication for a 24 to 48 hour period (withdrawal of
medication time-frame based on product information indicating extremely low mean drug
plasma concentrations between 24 and 48 hours after taking stimulant medication; U.S.
Food and Drug Administration, 2007). The time-frame between test and retest for this
group was approximately one week (M = 6.75, SD = 0.71). The demographics
questionnaire, BAARS-IV, and WAIS-IV subtests were completed while the clinical
participants were taking prescribed dosages of ADHD medication to minimize potential
discomfort associated with the return of ADHD symptomatology combined with a
relatively long research process. The Current Symptoms form of the BAARS-IV
questionnaire was completed while clinical participants were off of their prescribed
ADHD medication. Experimental task administration within the context of medication
status was counterbalanced so that half of the clinical participants completed the writing
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tasks while taking prescribed medication on their first visit, while the other half
completed the writing tasks while taking prescribed medication during their second visit.
To become familiarized with using the digitizing tablet and pen, all participants
began the writing task by signing their name on the digitizing tablet 10 times.
Subsequently, participants began writing experimental trials. No specific instructions
were given related to the quality of the handwriting participants were to produce beyond
pointing to the sample and telling the participants to “Write the word hello in cursive and
lower case as it is written on the card. Just write how you typically write.” When the
researcher was pressed further for additional instruction, participants were only told to
“Simply write how you typically write in cursive.” In the case of the novel symbol,
participants were instructed as follows: “Here is another symbol for the word ‘hello.’
Please write the symbol as demonstrated on the card.” If participants questioned whether
neatness was required, the investigator stated, “Just write it how you would write any
other word, but make it look like the symbol as demonstrated on the card.” Because
handwriting is variable within individuals, even when writing the same grapheme,
participants wrote each word and symbol 30 times in order to acquire a statistically stable
sample of handwriting. Finally, all participants were given the ability to manipulate the
position of the tablet to one that was comfortable for writing, as well as position the cards
containing the word “hello” and the novel symbol wherever was best for them.
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CHAPTER IV
ANALYSIS OF RESULTS
All data analyses were performed using IBM SPSS Statistics, Version 20.0.
Unless otherwise noted, an alpha level of .05 was used to determine statistical
significance. In addition, interpretations of effect sizes using ω2 were based on Kirk’s
(2003) guidelines, such that 0.010 was interpreted as a small association, 0.059 as a
medium association, and 0.138 or larger as a large association.
Data Analysis of Assumptions
Prior to hypothesis testing, the data were analyzed to determine adherence to the
assumptions of ANOVA, repeated measures ANOVA, and mixed design ANOVA.
Cumulatively, tested assumptions included normality of distribution and homogeneity of
variance. The assumptions of sphericity and homogeneity of variance/covariance
matrices by group were not analyzed due to the research design only incorporating two
levels of repeated measures. Assumptions were analyzed using the variables Estimated
IQ, Current Total ADHD Score, Childhood Total ADHD Score, NJ under the
automatized writing task condition, and RPV under both the automatized and novel
writing task conditions, with group membership (i.e., control versus clinical participants)
as the independent variable (IV).
Homogeneity of variance. Homogeneity of variance was assessed by first
identifying outlier variables (i.e., data with derived z-scores greater than |2.5|) and next
using Levene’s test of equality of error variances, with statistical significance of the latter
(i.e., p < .05) reflecting a potential violation of this assumption. The following outliers
were identified: one control participant within the Estimated IQ dependent variable (DV)
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and one clinical participant within both the NJ DV during automatized graphomotor
execution while on ADHD medication as well as within the NJ DV during automatized
graphomotor execution while off ADHD medication. In turn, all subsequent analyses of
assumptions were conducted with and without the inclusion of outliers for comparative
purposes. A significant Levene’s statistic was found between the variances of the ADHD
group on medication and control participants within the NJ DV during the automatized
writing task. No other statistical significance was found using Levene’s test, indicating
that the variation within conditions was roughly equivalent for all other comparisons.
When outliers were removed from the dataset, homogeneity of variance statistics
improved for the NJ DV during the automatized writing task when comparing control
participants versus clinical participants on ADHD medication, but statistical significance
persisted. Removing the outlier found within the Estimated IQ DV did not affect the
non-significant finding of Levene’s test of homogeneity of variance, and in fact moved
the data closer towards heterogeneity of variance.
It is important to note that ANOVA may be robust to violations of homogeneity
of variance when comparison groups are equal or nearly equal in size (i.e., the larger
group contains less than 1.50 times the number of participants than the smaller group)
and when the variance distribution between the largest and smallest variances is not
greater than a 4:1 ratio. The control group was 3.75 times larger than the clinical group
and 4.29 times larger than the clinical group for comparisons in which outliers were
removed. In addition, when outliers were retained, the variance distribution between the
largest and smallest variance in NJ data during the automatized writing task comparing
the ADHD group on medication and control participants was over 20:1. When outlier
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data was removed, the variance ratio in this comparison decreased substantially to almost
5:1. Variance data are presented in Table 2 and the results of homogeneity of variance
testing are summarized in Table 3.
Table 2
Variance of Data Within Conditions
Dependent
Variable

Group
Estimated IQ Control
ADHD

Variance
(With Outliers)
122.01
201.84

Variance
(Without Outliers)
88.92†
201.84

Current ADHD Control
ADHD

63.10
117.64

63.10
117.64

Childhood ADHD Control
ADHD

60.44
54.12

60.44
54.12

NJ – Auto Control
On Rx
Off Rx

50.66
1028.50
715.81

50.66
243.96†
98.98†

RPV – Auto Control
Off Rx

0.0015
0.0019

0.0015
0.0019

RPV – Novel Control
0.0026
0.0026
Off Rx
0.0037
0.0037
Note. IQ = Estimated Full Scale IQ; NJ = Normalized Jerk; RPV = Relative
Intraindividual Peak Velocity. Rx = Clinical/ADHD participants’ medication status (On
or Off medication). † = a change in value from “with outliers” to “without outliers.”
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Table 3
Levene’s Test of Homogeneity of Variance

F
Dependent
Group
Variable
Comparison
Estimated IQ Control vs. ADHD

df

Sig.

w
0.58

w/o
1.56

w
1, 36

w/o
1, 35

w
.45

w/o
.22

0.14

0.14

1, 36

1, 36

.71

.71

0.04

Current Control vs. ADHD
ADHD
Childhood Control vs. ADHD
ADHD
NJ – Auto Control vs. On Rx

0.04

1, 36

1, 36

.85

.85

22.50 10.02†

1, 36

1, 35

.00*

.00*

NJ – Auto Control vs. Off Rx

12.40

2.75†

1, 36

1, 35

.70

.08

NJ – Auto On Rx vs. Off Rx

0.30

1.25†

1, 14

1, 12

.59

.29

RPV – Auto Control vs. Off Rx

0.22

0.22

1, 36

1, 36

.64

.64

RPV – Novel Control vs. Off Rx

0.17

0.17

1, 36

1, 36

.68

.68

Note. Analyses of the assumption of homogeneity of variance within the data. IQ =
Estimated Full Scale IQ; NJ = Normalized Jerk, RPV = Relative Intraindividual Peak
Velocity; Auto = automatized writing condition; Rx = ADHD participants’ medication
status (On or Off medication); w = results with outliers; w/o = results without outliers.
* = statistical significance (p < .05) and violation of the assumption of homogeneity of
variance. † = a change in value from “with outliers” to “without outliers.”
Normality and Independence of Observations. The assumption of normality
was tested by analyzing skewness, kurtosis, and Shapiro-Wilk statistics. With the
inclusion of outlier scores, skewness z-scores were outside conventional cut-offs of
significance (i.e., skewness greater than |2|) for the NJ DV within the control group under
the automatized condition as well as for the NJ DV within the clinical group off ADHD
medication, both of which indicated a positive skew and a potential violation of the
assumption of normality. All other cells did not reflect significant positive or negative
skewness. Kurtosis z-scores, however, were greater than conventional cutoffs (i.e.,
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kurtosis greater than |3|) for the NJ DV under the automatized writing task for controls,
clinical participants on ADHD medication, and clinical participants off ADHD
medication, indicating significant leptokurtic kurtosis. The Shapiro-Wilk statistic was
also statistically significant for these same cells as well as for the Current Total ADHD
Score as measured by the BAARS-IV. Within the RPV DV, no significant skewness or
kurtosis was observed, and the Shapiro-Wilk statistic was non-significant for all data
cells for this variable. This in turn indicated that RPV results represented the only
normally distributed experimental data. Removing outlier data resulted in normalizing
the distribution of data with regard to skewness and kurtosis for all data cells with the
exception of the NJ DV under the automatized writing task within the control group,
which retained its significantly positive skew and significantly leptokurtic distribution.
In addition, the NJ DV under the automatized writing task continued to produce a
significant Shapiro-Wilk statistic within the clinical participant group on ADHD
medication.
ANOVA is said to be robust to violations of normality when sample sizes are
large and group sizes are roughly equivalent. Noting the relatively small sample size and
large group size differences within the sample, the violations of normality found within
the NJ DV while retaining outlier variables would significantly impact the reliability of
the ANOVA F statistic for all comparisons involving the NJ DV. Removing outlier data
normalized the distribution of NJ results for clinical participants off ADHD medication,
but not for NJ results for the control group or clinical participants on ADHD medication.
Tests of normality data, with and without outliers, are summarized in Table 4.

30

31

Table 4
Normality of Data

Skewness
Dependent
Variable
Estimated IQ

Kurtosis

Shapiro-Wilk

Group
Control
Clinical

w
0.58
-0.52

w/o
-0.14†
-0.52

w
1.03
-0.12

w/o
-0.70†
-0.12

w
.34
.78

w/o
.32†
.78

Current Total Control
ADHD Score Clinical

1.10
0.30

1.10
0.30

1.58
-1.72

1.58
-1.72

.03*
.20

.03*
.20

Childhood Total Control
ADHD Score Clinical

0.02
-0.40

0.02
-0.40

-1.14
-1.14

-1.14
-1.14

.23
.31

.23
.31

NJ – Auto Control
On Rx
Off Rx

2.28*
1.89
2.19*

2.28*
1.40†
1.11†

7.63*
3.53*
5.09*

7.63*
0.73†
0.44†

.00*
.01*
.00*

.00*
.03*†
.17†

RPV - Auto Control
Off Rx

0.02
1.38

0.02
1.38

0.10
1.88

0.10
1.88

.31
.15

.31
.15

RPV - Novel Control
Off Rx

0.42
0.93

0.42
0.93

-0.89
-0.86

-0.89
-0.86

.06
.06

.06
.06

Note. Analyses of the assumption of normality of distribution within the data. NJ =
Normalized Jerk; RPV = Relative Intraindividual Peak Velocity; Auto = Automatized
writing task; Rx = ADHD participants’ medication status (On or Off medication); w =
results with outliers; w/o = results without outliers. * = statistical significance (p <
.05) and violation of the assumption of normality. † = a change in value from “with
outliers” to “without outliers.”
Finally, data were gathered from participants in individual sessions. Combined
with the general novelty of the experimental tasks utilized, lack of known organized
communication between participants, and the manner in which data were gathered, it is
unlikely that participants’ scores were systematically related.
Taken together, the non-normally distributed data on the NJ DV for control
participants and clinical participants on ADHD medication combined with the
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heterogeneity of variance found comparing these two groups increases the risk of Type 1
errors when conducting analyses based on NJ data. In addition, largely unequal sample
sizes and variance distributions greater than 4:1 make conclusions drawn from NJ DV
results during the automatized writing task tenuous due the additional violation in the
assumption of normality. Again, removing outlier data improved the normality of the
data, but did not eliminate non-normality entirely. Given the above stated issues
associated with the data and the assumptions of ANOVA, 1) all subsequent analyses were
conducted without the presence of outlier scores on the NJ DV and 2) nonparametric
statistical analyses were also conducted for comparisons between control and clinical
participants on ADHD medication that involve using the NJ DV in order to provide
support for, or against, significant findings that were found using parametric statistics.
Demographics and ADHD Symptomatology
Data pertaining to participant demographics, estimated IQ, and presence of
ADHD symptomatology were collected for the purposes of sample description.
ANOVAs were performed to determine significant initial group differences when
appropriate.
In the overall sample, more participants were right-handed (84.21%) than lefthanded (15.79%), more women (78.95%) participated in the study than men (21.05%),
and a majority of the participants self-identified as Caucasian (71.05%). Between the
control and clinical participant groups, a greater proportion of clinical participants were
left-handed (37.50%) than control participants (10.00%). Fortunately, kinematic
variables have not been shown to be affected by handedness alone (Mergl et al., 1999).
There was a greater proportion of men in the clinical participant sample (62.50%) than in

32

33

the control participant sample (10.00%). A slightly greater representation of nondominant ethnic/racial group members was also observed in the clinical participant
sample (33.33%) versus the control participant sample (20.00%).
Overall, control participants (M = 27.56, SD = 11.91) were younger than clinical
(M = 35.00, SD = 9.08) participants, but not significantly, F(1, 36) = 2.69, p = .110, and
with a small effect size, ω2 = .043. There was, however, a broader age range in control
participants (age range: 18.58–54.08 years) versus clinical participants (age range: 23.25–
46.60 years). Control (M = 94.17, SD = 11.05) and ADHD (M = 94.88, SD = 14.21)
participants performed nearly identically on the general test of intellectual ability as a
group, F(1, 36) = 0.02, p = .880, ω2 = .000, with both groups falling within the average
range. Please see Table 5 for a summary of all participant demographic information.
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Table 5
Participant Demographic Information
Control
M

SD

27
3

-

-

5
3

-

-

Women
Men

27
3

-

-

3
5

-

-

Race/Ethnicity
Asian
Black
Caucasian
Hispanic

2
3
24
1

-

-

0
1
6
1

-

-

n
Handedness
Right
Left

ADHD
M

n

SD

Sex

Age

-

27.56

11.91

-

35.00

9.08

Estimated IQ

-

94.17

11.05

-

94.88

14.21

Note. Estimated IQ = estimate of general intellectual ability. ADHD =
clinical participants diagnosed with ADHD.
Participant ratings of ADHD symptomatology as measured by the BAARS-IV are
summarized in Table 6. Clinical participants rated current ADHD symptomatology (M =
48.88, SD = 7.86) as occurring significantly more frequently than control participants (M
= 30.00, SD 7.94), F(1, 36) = 35.80, p < .001, with an observed large effect size, ω2 =
.478. In addition, clinical participants reported significantly more symptoms of ADHD
that occurred during childhood (M = 50.88, SD = 7.36) than did control participants (M =
30.67, SD = 7.77), F(1, 36) = 43.56, p < .001, also with a large effect size, ω2 = .528.
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Table 6
BAARS-IV ADHD Symptomatology

Current Symptom Total
ADHD Score:
Childhood Symptom
Total ADHD Score:

Control
M
SD
30.00 7.94

Clinical
M
SD
48.88 7.86

30.67

50.88

7.77

7.36

As shown in Table 7, a greater proportion of clinical participants also reported
clinically significant levels of current (100%) and childhood (87.50%) ADHD
symptomatology compared to control participants (significant levels of current ADHD
symptomatology = 13.3%, significant levels of childhood ADHD symptomatology =
0%). Taken together, it can be reasonably concluded that clinical participants reported
significantly higher levels of current and childhood ADHD symptoms than control
participants. Finally, ADHD subtypes diagnosed in clinical participants included ADHDC (n = 5), ADHD-PI (n = 1), and ADHD-HI (n = 2).
Table 7
Number of Participants with BAARS-IV Scores ≥ 93rd %tile

Current Symptom Total
ADHD Score:
Childhood Symptom
Total ADHD Score:

Control
n
4 (13.30%)

Clinical
n
8 (100%)

0 (0.00%)

7 (87.50%)
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Kinematic Analyses
Overlap with past research. Due to multiple comparisons and the relatively low
risk involved with rejecting a true null hypothesis, a Bonferroni correction was used for
all statistical comparisons. As such, the alpha level for statistical comparisons made to
determine support for past research was adjusted to .02. Two One-Way ANOVAs were
used to compare the handwriting fluency of controls with clinical participants both on
ADHD medication as well as off ADHD medication. Between group comparisons based
on fluency measures detected no statistically significant differences between control (M =
18.43, SD = 7.12) and clinical participants taking ADHD medication (M = 25.57, SD =
15.62), F(1, 35) = 3.45, p = .072, but did demonstrate a medium effect size, ω2 = .062.
This non-significant finding was consistent with previous research. Nonparametric
statistical analysis (i.e., the Mann-Whitney U Test) also indicated that this difference was
not statistically significant, p = .435, and that the null hypothesis should be retained. The
handwriting fluency scores of clinical participants off ADHD medication (M = 21.10, SD
= 10.47) compared to those of control participants (M = 18.43, SD = 7.12) were not
significantly different, F(1, 35) = 0.66, p = .421, and demonstrated an uninterpretable
effect size, ω2 = .000. Combined, these non-significant findings are consistent with
previous research.
A repeated measures One-Way ANOVA was used to examine automatized
handwriting fluency (i.e., NJ) of clinical participants taking ADHD medication versus
those same participants discontinuing their ADHD medication for 24 hours. The results
comparing the handwriting fluency of clinical participants on ADHD medication (M =
25.57, SD = 15.62) versus off ADHD medication (M = 21.10, SD = 10.47) did not
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identify a statistically significant difference, F(1, 6) = 1.51, p = .265. This result is
consistent with previous findings in that handwriting fluency of clinical participants did
not differ significantly based on medication status. Although not a statistically
significant difference, a medium effect size was found, ω2partial = .068. See Table 8 for a
summary of automatized fluency results as well as source data for statistical comparisons
and Figure 3 for a graphical comparison of the automatized writing fluency of control
participants versus clinical participants both on and off ADHD medication.
Table 8
Automatized Writing Fluency – Summary and Source Table

Source
Group Membership
Error Between
Control
On Rx

M
18.43
25.57

SD
SS
289.14
2932.99
7.12
15.62
-

Group Membership
Error Between
Control
Off Rx

18.43
21.01

40.24
2127.38
7.12
10.47
-

Medication Status
Error Residual
On Rx
Off Rx

-

-

25.57
21.10

15.62
10.47

70.09
278.44
-

df

MS
1 289.14
35 83.80
-

p
.072
-

ω2
.062
-

1
35

40.24
60.78
-

0.66
-

.421
-

.000
-

1
6

70.09
46.41
-

1.51
-

.265
-

.068†
-

-

-

F
3.45
-

Note. On Rx = ADHD/Clinical participants on ADHD medication; Off Rx =
ADHD/Clinical participants off ADHD medication. M = mean of normalized jerk (NJ)
value; SD = standard deviation of normalized jerk (NJ) value. † = partial omega-squared.

37

38

Automatized Writing Fluency
30.00
25.00
20.00
15.00
10.00
5.00
0.00

NJ

Control
18.43

ADHD On Rx
25.57

ADHD Off Rx
21.10

Figure 3. Automatized writing fluency of control and clinical participants. NJ =
Normalized Jerk. Higher values of NJ indicate more dysfluent writing, whereas lower
values of NJ indicate more fluent and automatized writing. ADHD On Rx =
ADHD/Clinical participants on ADHD medication; ADHD Off Rx = ADHD/Clinical
participants off ADHD medication.
Variability of graphomotor performance. The alpha level was set at .05 to
indicate statistical significance for the following comparisons. A One-Way ANOVA was
used to analyze the kinematic variability of automatized handwriting performance (i.e.,
RPV) of healthy control participants with that of ADHD participants that discontinued
ADHD medication for 24 hours. No main effect was found related to group membership
and variability of graphomotor performance, F(1, 36) = 0.37, p = .545, and no
interpretable effect size was found, ω2 = .000, indicating that clinical participants not
taking ADHD medication (M = 0.12, SD = 0.06) demonstrated similar variability in
automatized graphomotor performance to control participants (M = 0.13, SD = 0.04). See
Table 9 for a summary of graphomotor variability findings as well as source information.
See Figure 4 for a graphical comparison of graphomotor variability findings.
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Table 9
Automatized Writing Variability – Summary and Source Table

Source
Group Membership
Error Between
Control
Off Rx

M
.13
.12

SD
.04
.04

SS
.001
.057
-

df
1
36
-

MS
.001
.002
-

F
0.37
-

p
.545
-

ω2
.000
-

Note. Off Rx = ADHD/Clinical participants off ADHD medication. M = mean of the
relative intraindividual mean peak velocity (RPV) value; SD = standard deviation of the
relative intraindividual mean peak velocity (RPV) value.

Automatized Writing Variability
0.30
0.25
0.20
0.15
0.10
0.05
0.00

RPV

Control
0.13

ADHD Off Rx
0.12

Figure 4. Variability of handwriting performance in control and clinical participants.
RPV = Relative Intraindividual Mean Peak Velocity. Less consistently controlled
movements are indicated by higher values and more consistently controlled movements
reflected by lower values. ADHD Off Rx = ADHD/Clinical participants off ADHD
medication.
The effects of novelty on variability. A 2 x 2 factorial mixed design ANOVA
was used to compare the effects of novelty on variability measures in those diagnosed
with ADHD off medication versus healthy controls. There was a significant main effect
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for writing task, F(1, 36) = 24.86, p < .001, indicating that overall, more variable and less
consistent handwriting was seen in participants when performing the novel writing task
(M = 0.18, SD 0.06) versus the automatized writing task (M = 0.12, SD = 0.04). The
effect size for the writing task main effect was large, ω2partial = .333. However, no
significant interaction effect was observed, F(1, 36) = 0.11, p = .740, with no
interpretable effect size, ω2partial = .000. See Table 10 for source information pertaining to
graphomotor variability findings as a function of writing task. See Figure 5 for a
graphical comparison of graphomotor variability findings related to writing task.
Table 10
Graphomotor Variability as a Function of Novelty –Source Table

Source

SS

df

Within Subjects
Writing Task 0.040003
Error Within 0.057937
Interaction
Writing Task x Group 0.000180
Membership
Error Interaction 0.057937
Note. * = statistical significance p < .05
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MS

1 0.040003
32 0.001609

1 0.000180
32 0.001636

F

p

24.86 <.001*
-

0.11
-

.740
-

ω2
.333
-

.000
-
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Graphomotor Variability as a Function of Novelty
0.19
0.18
0.17
0.16
0.15
0.14
0.13
0.12
0.11
0.10
Control
ADHD Off Rx

Automatized RPV
0.13
0.12

Novel RPV
0.18
0.17

Figure 5. Handwriting variability based on writing task. RPV = Relative Intraindividual
Mean Peak Velocity. Less consistently controlled movements are indicated by higher
values and more consistently controlled movements reflected by lower values. ADHD
Off Rx = ADHD/Clinical participants off ADHD medication.
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CHAPTER V
CONCLUSIONS AND RECOMMENDATIONS
Discussion
Utilizing a digitizing tablet and specialized kinematic analyses software to
quantify graphomotor performance during putatively automatized and novel writing
tasks in adults with and without a diagnosis of ADHD, the present study sought to: 1)
determine whether the variability of performance observed in other psychological
domains in those diagnosed with ADHD would manifest within kinematic variables
associated with stability and coordination of graphomotor output (i.e., RPV) and 2)
determine whether a novel writing task would differentially affect the variability of
graphomotor output of adults diagnosed with ADHD compared to healthy controls.
Overlap with past research. Consistent with prior research (Tucha & Lange,
2004), results of the present study suggest that automatized graphomotor fluency, as
measured by kinematic analysis, is not significantly different in adults diagnosed with
ADHD taking prescribed dosages of stimulant medication from that of neurotypical
adults. This conclusion was supported using both parametric and nonparametric
statistical analysis. Despite these non-statistically significant findings that appear to
corroborate past research, this conclusion should be accepted cautiously. Findings of
statistical significance using ANOVA or other analyses under the general linear model
are affected by sample size. That is, as sample size increases, the likelihood of finding a
statistically significant result continues to increase, even when differences in performance
are relatively small. As such, the power of the research design, which takes into account
sample size, effect size, and alpha level, must also be considered. Noting the medium
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effect size (ω2 = .062) and the relatively small number of clinical participants (n = 7)
within this study, it is likely that this non-statistically significant finding is due to low
power rather than non-significant differences between healthy adults and adults
diagnosed with ADHD on stimulant medication. In turn, a statistically significant result
may have been found if the clinical sample was larger and fluency results within the
study maintained the same pattern.
Also consistent with previous research, adults diagnosed with ADHD off
medication produced similarly fluent automatized graphomotor output as control
participants without ADHD. Although an argument could be made that increased power
via a larger sample of clinical participants may result in the formulation of a different
conclusion, the extremely small (and uninterpretable) effect size observed in this study
combined with both the adherence to the assumptions of ANOVA and findings that are
consistent with previous research strongly suggest that this conclusion is reliable and
valid.
Concerning the handwriting fluency of adults diagnosed with ADHD on stimulant
medication versus those same adults off ADHD medication, the present study was
consistent with previous research indicating no statistically significant difference in
automatized graphomotor fluency. This finding suggests that medication status may not
affect the graphomotor fluency of adults diagnosed with ADHD when performing an
automatized writing task. Again, this interpretation must be made with caution. Similar
to the above results comparing the automatized graphomotor fluency of control
participants with that of clinical participants on ADHD medication, the medium effect
size (ω2 = .068) found in the comparison of adults with ADHD on medication versus off
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medication suggests that non-significant findings could be the result of insufficient
statistical power associated with a small clinical participant sample.
However, if statistical power were sufficient and statistically significant findings
related to differences in automatized graphomotor fluency were found between adults
with ADHD on stimulant medication versus off ADHD medication, as well as between
adults with ADHD on stimulant medication versus control participants, results would still
need to be interpreted cautiously due to other methodological considerations. First,
graphomotor fluency in previous research was operationalized as the mean number of
inversions in the direction of vertical velocity over time (Tucha & Lange, 2004). In this
study, however, graphomotor fluency was operationalized as normalized jerk, which is
derived from the number of changes in acceleration in time (analogous to the number of
changes in velocity over time) but was then normalized due to the effects of size and
duration of movements on fluency measures (Tuelings et al., 1997). Using the NJ
variable as opposed to the mean number of inversions in velocity provided the benefit of
validly comparing graphomotor fluency of the word “hello” and the symbol “

.”

However, the NJ variable may not be completely analogous to previously used measures
quantifying automatized graphomotor fluency in adults with ADHD. As such, the
derived fluency measures of this study may not be completely comparable with those of
past research investigating graphomotor fluency in adults with ADHD.
Secondly, the previous study investigating graphomotor fluency in adults
diagnosed with ADHD analyzed the specific letter combination of “ll” within two
German words (Tucha & Lange, 2004). The present study, however, analyzed the entire
word “hello” to determine automatized graphomotor fluency. Intuitively, the
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biomechanical forces necessary to generate the letters “ll” versus the word “hello” are
different based upon salient graphemic differences. In turn, conclusions drawn from
comparisons between the current study and past research should be done with caution
noting that differences in graphomotor fluency findings may be due, at least in part, to the
experimental stimulus used.
Variability of graphomotor performance. Using the kinematic variable RPV,
clinical participants exhibited variability in graphomotor output when executing an
automatized writing task that was similar to that of control participants. As such, the
results of this study suggest that the variability of performance observed in various
psychological domains (e.g., emotional expression, handwriting production, fine motor
skill movements, motor coordination, and motor force output) within the ADHD
population may not be manifest within the kinematic measures of stability, consistency,
and coordination used in this study, in which participants performed an automatized
graphomotor task.
This was the first such research to utilize RPV as a measure of variability of
graphomotor performance in adults diagnosed with ADHD. Previous research utilizing
the RPV measure to study kinematic aspects of handwriting in clinical populations
focused on patients diagnosed with probable Alzheimer’s dementia (AD) (Schroter et al.,
2003). In this research, Schroter and colleagues found that when performing a spiral
drawing task, participants with probable AD exhibited significantly more variability,
incoordination, and greater inconsistency in the kinematics of handwriting movements
compared to similarly aged healthy control participants. One of the primary rationales
for conducting this study was the high co-occurrence of salient motor dysfunction found
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within the AD population: a high prevalence of Parkinsonism and various extrapyramidal
motor symptoms. Although motor problems have also been documented in those with
ADHD, motor sequelae in the ADHD population may be more subtle than what is
observed in patients with AD. Accordingly, a failure to demonstrate significant
differences in consistency of graphomotor output between adults with ADHD and healthy
controls could be the result of less than optimal sensitivity of the RPV measure in
detecting subtle motor differences in the ADHD population.
Further, how the RPV measure was derived may have created an insensitive
measure that failed to detect intraindividual variability of graphomotor production. That
is, the mean peak velocity was collapsed across all strokes within each trial and then
averaged with all 30 trials of each writing task. The RPV, which is a coefficient of
variation (CV), was then determined for each participant by dividing the standard
deviation of the mean peak velocities by the average of the mean peak velocities across
all trials. As such, this collapsed mean may not have optimally reflected variability of
graphomotor performance with sufficient sensitivity because variability within each
individual writing trial was not taken into consideration when calculating the RPV. Said
another way, deriving the RPV variable to indicate intraindividual variability by creating
a CV based on the averages and standard deviation of mean peak velocities across all
trials rather than deriving the RPV variable based upon an average of the coefficients of
variation of mean peak velocities calculated within each trial may have underestimated
the intraindividual variability of automatized and novel graphomotor output.
The writing tasks themselves may also not have optimally allowed participants to
demonstrate significant variability of graphomotor performance. For example, previous
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work utilizing the RPV variable has demonstrated no statistically significant differences
in intraindividual variability of handwriting between men and women when writing
letters or simple geometric figures (Mergl et al., 1999). However, in this same study,
statistically significant gender differences in intraindividual variability of graphomotor
performance emerged when participants executed a six word sentence.
Bearing in mind the methodological and statistical considerations mentioned
above, the findings of the present study suggest the following: 1a) conclusions
concerning the fluency of automatized graphomotor performance in healthy controls as
compared with adults diagnosed with ADHD taking stimulant medication can only be
tentatively drawn at this time. These findings, in combination with past findings, suggest
that the automatized graphomotor fluency between these groups is similar. However,
medium effect sizes suggest that real differences may be present and would be detected if
statistical power were greater. 1b) A negligible observed effect size, non-significant
findings, and replication of past research provide strong evidence that the graphomotor
fluency of adults with ADHD off stimulant medication is similar to the fluency of
individuals without ADHD. 2) Conclusions regarding the fluency of automatized
graphomotor performance in adults with ADHD on stimulant medication versus off
ADHD medication can only be tentatively drawn. The medium effect size found within
this comparison suggests potential differences in automatized graphomotor fluency in
adults with ADHD on stimulant medication versus off medication. 3) Variability of
performance, as measured by the RPV variable, does not appear to manifest within the
graphomotor domain in adults diagnosed with ADHD. However, more sensitive
measures of intraindividual variability of graphomotor performance or different writing
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tasks may yield different results and in turn, support an alternative conclusion. 4) The
novelty of a graphomotor task does not appear to differentially affect the variability of
kinematic handwriting performance in adults diagnosed with ADHD as measured by the
RPV variable. As mentioned previously concerning the RPV variable, however, different
results may be found by calculating a more sensitive measure of intraindividual
variability of graphomotor performance.
An additional aim of this study was to add to the current literature demonstrating
that ADHD is not simply a disorder of childhood, but rather, a condition that involves
specific motor differences that persist into adulthood. Although differences in motor
functioning as measured by the kinematic analyses utilized in this study were not
statistically significant, effect size differences and methodological considerations do not
support the conclusion that motor symptoms do not persist into adulthood. Rather, the
results of this study support implementing improved methodology and statistical analyses
to further explore potential motor skill differences in those with ADHD that may persist
into adulthood.
Further, this study aimed to find support for the use of digitizing technology as an
objective diagnostic and descriptive tool within the ADHD population, which would in
turn enhance the specificity and/or sensitivity of current assessment and diagnostic
techniques. Although significant differences in graphomotor function were not observed
between adults with ADHD and healthy controls utilizing the proposed kinematic
analyses, when considering the methodological and statistical concerns associated with
this study, it is likely too early to conclude that kinematic analysis utilizing digitizing
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technology would not create an added benefit when attempting to describe graphomotor
performance differences in the adult ADHD population versus unaffected adults.
Methodological Limitations. This project began with several pragmatic
considerations, including researching and obtaining appropriate hardware and software,
developing research protocols, and learning how to interpret the results of kinematic
analyses based on digitizing technology. As such, the present study served as a
foundation for future kinematic research utilizing digitizing technology in an effort to
understand fine motor and graphomotor skill performance of adults and children with
ADHD. An additional benefit of this study was to implement a novel protocol and
evaluate the feasibility of future research questions. Although this was not a direct goal,
the results and implementation of this project did have the benefit of establishing the
limitations of kinematic research utilizing digitizing technology. Nevertheless,
methodological limitations and limitations of statistical analyses used may have affected
the results, and in turn the conclusions of this study.
Beyond the concerns mentioned above, the primary limitation of this study was
the small number of clinical participants that were recruited and as such, low statistical
power. Post-hoc power analyses using G*Power software (Buchner, Erdfelder, Faul, &
Lang, 2009) confirmed the low power of this study, which ranged from 1-β = .19 to 1-β =
.74 for all statistical analyses. In addition, when sample sizes are small, data are unstable
and yield statistics that are unreliable. An additional problem that this small clinical
sample size created was a situation in which the two comparison groups were largely
unequal in size. This additional problem further decreases the reliability of the F statistic
and its ability to help draw conclusions. In the future, recruitment strategies should
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involve broadening the pool from which clinical participants are drawn by increasing the
number of sources from which participants are recruited. However, the present study
could also be considered an initial work in progress, with additional recruitment of
participants scheduled to occur in the future.
In addition, parametric statistical analyses in this study utilized the general linear
model. These statistical analyses used to determine both group differences in the
variability of automatized graphomotor performance and the effect of novelty on these
measures of variability may not have been sufficiently sensitive in detecting
intraindividual differences. For example, King, Harring, Oliveira, and Clark (in press)
utilized both a general linear model statistic (i.e., ANOVA) as well as a random
coefficient model technique to study intra- and inter-individual variability of motor
movements in healthy children and children diagnosed with DCD. In summary, King
and colleagues found that the random coefficient model identified intra- and interindividual differences in task execution that the general linear model analysis did not
detect. As such, the use of ANOVA to analyze intraindividual differences in automatized
graphomotor performance may not have been the most appropriate or sensitive statistical
model for the purposes of this research question.
Future Research
The results and methodology used in this study suggest multiple lines of research
that should be explored in the future. First, the present study sought to understand the
variability of graphomotor performance using a CV derived from the average of mean
peak velocities for each word or symbol across 30 trials. Alternatively, variability could
be expressed as a CV of average fluency results in both automatized and novel writing
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tasks. That is, variability of graphomotor performance in adults with ADHD could be
explored using a derivative of the NJ variable rather than a derivative of mean peak
velocity. In addition, and as mentioned above, future research should attempt to
understand variability of graphomotor performance by utilizing an alternative calculation
of the intraindividual variation of graphomotor functioning. This would involve
computing the average of the CVs of mean peak velocity per trial rather than the CV of
the average mean peak velocity collapsed across all trials. Finally, future research into
intraindividual variability of performance could benefit from using more powerful and
elegant statistical analyses. As demonstrated by King et al. (in press), the use of
statistical techniques based upon a random coefficient model may have greater power to
detect intraindividual differences in motor skill performance than do techniques based
upon the general linear model.
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APPENDICES
APPENDIX A
Interview Questionnaire
Name: _____________________________________
In what month and year were you born? _________________________
How would you describe your Sex or Gender? _____________________
What hand do you primarily use to write with? Right Hand Left Hand
Ambidextrous
What medications are you currently taking? Please include dosage information.
Medication

Dosage

Medication

Dosage

Some people use terms such as Arabic, Asian, Black, Hispanic, White, or similar
terms to describe their ethnicity. What term would you use to describe your
ethnicity? ______________
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Do you currently have a diagnosis of ADHD? If yes, what is that official diagnosis?
________________________________________________________________________
Do you have a current diagnosis or diagnoses affecting the central nervous system
or peripheral nervous system that would impair your ability to take part in a
writing task? An example of central nervous system diagnosis affecting writing
ability includes cerebral palsy affecting the arms and/or hands, and an example of
peripheral nervous system diagnosis affecting writing ability includes carpal tunnel.
________________________________________________________________________
________________________________________________________________________

Is there any other information that you feel may affect your participation in this
study that you would like me to know?
________________________________________________________________________
________________________________________________________________________
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APPENDIX B

Figure B1. Scaled version of novel symbol.

54

REFERENCES
Adi-Japha, E., Landau, Y. E., Frenkel, L., Teicher, M., Gross-Tsur, V., & Shalev, R. S.
(2007). ADHD and dysgraphia: Underlying mechanisms. Cortex, 43, 700-709.
doi:10.1016/S0010-9452(08)70499-4
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental
disorders (4th ed., text rev.). Arlington, VA: Author.
American Psychiatric Association. (2010). DSM-5: Options being considered for ADHD.
Retrieved from
http://www.dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx?rid=383#
Amico, F., Stauber, J., Koutsouleris, N., & Frodi, T. (2010). Anterior cingulated cortex
gray matter abnormalities in adults with attention deficit hyperactivity disorder: A
voxel-based morphometry study. Psychiatry Research: Neuroimaging, 191, 3135. doi:10.1016/j.pscychresns.2010.08.011
Arnsten, A. F. T., Berridge, C. W., & McCracken, J. T. (2009). The neurobiological basis
of Attention-Deficit/Hyperactivity Disorder. Primary Psychiatry, 16, 47-54.
Banaschewski, T., Becker, K., Scherag, S., Franke, B., & Coghill, D. (2010). Molecular
genetics of attention-deficit/hyperactivity disorder: An overview. European Child
& Adolescent Psychiatry, 19(3), 237-257. doi:10.1007/s00787-010-0090-z
Barkley, R. A. (2006). Attention-deficit hyperactivity disorder: A handbook for diagnosis
and treatment (3rd ed.). New York: Guilford Press.
Barkley, R. A. (2011). Barkley adult ADHD rating scale-IV (BAARS-IV). New York:
Guilford Press.

55

56
Barkley, R. A., & Fischer, M. (2010). The unique contribution of emotional
impulsiveness to impairment in major life activities in hyperactive children as
adults. Journal of The American Academy of Child & Adolescent Psychiatry, 49,
503-513. doi:10.1097/00004583-201005000-00011
Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2002). The persistence of
attention-deficit/hyperactivity disorder into young adulthood as a function of
reporting source and definition of disorder. Journal Of Abnormal Psychology,
111, 279-289. doi:10.1037/0021-843X.111.2.279
Bart, O., Podoly, T., & Bar-Haim, Y (2010). A preliminary study on the effect of
methylphenidate on motor performance in children with comorbid DCD and
ADHD. Research in Developmental Disabilities, 31, 1443-1447.
doi:10.1016/j.ridd.2010.06.014
Batty, M. J., Liddle, E. B., Pitiot, A., Toro, R., Groom, M. J., Scerif, G., . . . Hollis, C.
(2010). Cortical gray matter in Attention-Deficit/Hyperactivity Disorder: A
structural magnetic resonance imaging study. Journal of the American Academy
of Child and Adolescent Psychiatry, 49, 229-238. doi:10.1016/j.jaac.2009.11.008
Bellgrove, M. A., Phillips, J. G., Bradshaw, J. L., Hall, K. A., Presnell, I., & Hecht, H.
(1997). Response programming in dementia of the Alzheimer type: A kinematic
analysis. Neuropsychologia, 35, 229-240. doi:10.1016/S0028-3932(96)00081-4
Biederman, J. (2005). Attention-Deficit/Hyperactivity Dosorder: A selective overview.
Biological Psychiatry, 57, 1215-1220. doi:10.1016/j.biopsych.2004.10.020

57
Biederman, J., Petty, C. R., Clarke, A., Lomedico, A., & Faraone, S. V. (2011).
Predictors of persistent ADHD: An 11-year follow-up study. Journal Of
Psychiatric Research, 45, 150-155. doi:10.1016/j.jpsychires.2010.06.009
Bo, J., Bastien, A. J., Kagerer, F. A., Contreras-Vidal, J. L., & Clark, J. E. (2008).
Temporal variability in continuous versus discontinuous drawing for children
with Developmental Coordination Disorder. Neuroscience Letters, 431, 215-220.
doi:10.1016/j.neulet.2007.11.040
Brossard-Racine, M., Majnemer, A., & Shevell, M. I. (2011). Exploring the neural
mechanisms that underlie motor difficulties in children with Attention Deficit
Hyperactivity Disorder. Developmental Neurorehabilitation, 14(2), 101-111. doi:
10.3109/17518423.2010.547545
Brossard-Racine, M., Majnemer, A., Shevell, M., & Snider, L. (2008). Handwriting
performance in children with Attention Deficit Hyperactivity Disorder (ADHD).
Journal of Child Neurology, 23, 399-406. doi: 10.1177/08833073807309244
Brossard-Racine, M., Majnemer, A., Shevell, M., Snider, L., & Belanger, S. A. (2011).
Handwriting capacity in children newly diagnosed with Attention Deficit
Hyperactivity Disorder. Research in Developmental Disabilities, 32, 2927-2934.
doi:10.1016/j.ridd.2011.05.010
Brown, A. B., Biederman, J., Valera, E., Makris, N., Doyle, A., Whitfield-Gabrieli, S., . .
. Seidman, L. (2011). Relationship of DAT1 and adult ADHD to task –positive
and task-negative working memory networks. Psychiatry Research:
Neuroimaging, 193, 7-16. doi:10.1016/j.pscychresns.2011.01.006

58
Buchner, A., Erdfelder, E., Faul, F., & Lang, A. (2009). G*Power (Version
3.1.2)[Computer program]. http://www.psycho.uniduesseldorf.de/aap/projects/gpower/
Bush, G., Frazier, J. A., Rauch, S. L., Seidman, L. J., Whalen, P. J., Jenike, M. A., & ...
Biederman, J. (1999). Anterior cingulate cortex dysfunction in attentiondeficit/hyperactivity disorder revealed by fMRI and the Counting Stroop.
Biological Psychiatry, 45, 1542-1552. doi:10.1016/S0006-3223(99)00083-9
Castellanos, F., Giedd, J. N., Berquin, P. C., Walter, J. M., Sharp, W., Tran, T., . . .
Rapoport, J. L. (2001). Quantitative brain magnetic resonance imaging in girls
with attention-deficit/hyperactivity disorder. Archives Of General Psychiatry, 58,
289-295. doi:10.1001/archpsyc.58.3.289
Castellanos, F., Giedd, J. N., Marsh, W. L., & Hamburger, S. D. (1996). Quantitative
brain magnetic resonance imaging in attention-deficit hyperactivity disorder.
Archives Of General Psychiatry, 53, 607-616.
Chang, S.-H. & Yu, N.-Y. (2010). Characterization of motor control in handwriting
difficulties in children with or without developmental coordination disorder.
Developmental Medicine & Child Neurology, 52, 244-250. doi: 10.1111/j.14698749.2009.03478.x
Cubillo, A., Halari, R., Giampietro, V., Taylor, E., & Rubia, K. (2011). Fronto-striatal
underactivation during interference inhibition and attention allocation in grown up
children with attention deficit/hyperactivity disorder and persistent symptoms.
Psychiatry Research: Neuroimaging, 193, 17-27.
doi:10.1016/j.pscychresns.2010.12.014

59
Daly, G. G., Hawi, Z. Z., Fitzgerald, M. M., & Gill, M. M. (1999). Mapping
susceptibility loci in attention deficit hyperactivity disorder: preferential
transmission of parental alleles at DAT1, DBH and DRD5 to affected children.
Molecular Psychiatry, 4, 192-196.
Dooijes, E. H. (1983). Analysis of handwriting movements. Acta Psychologica, 54, 9114. doi:10.1016/0001-6918(83)90026-4
Durston, S., Hulshoff Pol, H. E., Schnack, H. G., Buitelaar, J. K., Steenhuis, M. P.,
Minderaa, R. B., & ... van Engeland, H. (2004). Magnetic resonance imaging of
boys with attention-deficit/hyperactivity disorder and their unaffected siblings.
Journal Of The American Academy Of Child & Adolescent Psychiatry, 43, 332340. doi:10.1097/00004583-200403000-00016
Durston, S., Tottenham, N. T., Thomas, K. M., Davidson, M. C., Eigsti, I., Yang, Y., . . .
Casey, B. J. (2003). Differential patterns of striatal activation in young children
with and without ADHD. Biological Psychiatry, 53, 871-878. doi:10.1016/S00063223(02)01904-2
Eichhorn, T. E., Gasser, T., Mai, N., Marquardt, C., Arnold, G., Schwarz, J, & Oertel, W.
H. (1996). Computational analysis of open loop handwriting movements in
Parkinson’s Disease: A rapid method to detect dopamimetic effects. Movement
Disorders, 11, 289-297.
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M.
A., & Sklar, P. (2005). Molecular Genetics of Attention-Deficit/Hyperactivity
Disorder. Biological Psychiatry, 57, 1313-1323.
doi:10.1016/j.biopsych.2004.11.024

60
Flapper, B. T., Houwen, S., & Schoemaker, M. M. (2006). Fine motor skills and effects
of methylphenidate in children with attention-deficit-hyperactivity disorder and
developmental coordination disorder. Developmental Medicine & Child
Neurology, 48, 165-169. doi:10.1017/S0012162206000375
Fliers, E. A., Franke, B., Lambregts-Rommelse, N. N. J., Altink, M. E., Buschgens, C. J.
M., Nijhuis-van der Sangen, M. W. G., . . . Buitelaar, J. K. (2009).
Undertreatment of motor problems in children with ADHD. Child Adolescent
Mental Health, 15, 85-90. doi:10.1111/j.1475-3588.2009.00538.x
Galli, M., Vimercati, S. L., Stella, G., Caiazzo, G., Norveti, F., Onnis, F., . . . Albertini,
G. (2011). A new approach for the quantitative evaluation of drawings in children
with learning disabilities. Research in Developmental Disabilities, 32, 1004-1010.
doi:10.1016/j.ridd.2011.01.051
Gangadhar, G., Joseph, D., Srinivasan, A. V., Subramanian, D., Shivakeshaven, R. G.,
Shobana, N., & Chakravarthy, V. S. (2009). A computational model of
Parkinsonian handwriting that highlights the role of the indirect pathway in the
basal ganglia. Human Movement Science, 28, 602-618.
doi:10.1016/j.humov.2009.07.008
Graham, S., & Weintraub, N. (1996). A review of handwriting research: Progress and
prospects. Educational Psychology Review, 8, 7. Retrieved from EBSCOhost.
Grootens, K. P., Vermeeren, L., Verkes, R. J., Buitelaar, J. K., Sabbe, B. G. C., van
Veelen, N., . . . Hulstijn, W. (2009). Psychomotor planning is deficient in recentonset schizophrenia. Schizophrenia Research, 107, 294-302.
doi:10.1016/j.schres.2008.09.032

61
Guerfali, W. & Plamondon, R. (1997). Effect of variability on letters generation with the
vectorial delta-lognormal model. In N. Murshed & F. Bortolozzi (Series, Ed.),
Advances in Document Image Analysis: Vol. 1339. Lecture Notes in Computer
Science (pp. 74-83). doi:10.1007/3-540-63791-5_5
Hynd, G. W., Semrud-Clikeman, M., Lorys, A. R., & Novey, E. S. (1991). Corpus
callosum morphology in attention deficit-hyperactivity disorder: Morphometric
analysis of MRI. Journal Of Learning Disabilities, 24, 141-146.
doi:10.1177/002221949102400302
Jahn, T., Cohen, R., Hubermann, W., Mohr, F., Kohler, I., Schlenker, R., . . . Schroder, J.
(2006). The Brief Motor Scale (BMS) for the assessment of motor soft signs in
schizophrenic psychoses and other psychiatric disorders. Psychiatry Research,
142(2-3), 177-189. doi:10.1016/j.psychres.2002.12.002
Kadesjö, B., & Gillberg, C. (2001). The comorbidity of ADHD in the general population
of Swedish school-age children. Journal of Child Psychology and Psychiatry, 42,
487-492. doi:10.1111/1469-7610.00742
King, B. R., Harring, J. R., Oliveira, M. A., & Clark, J. E. (in press). Statistically
characterizing intra- and inter-individual variability in children with
Developmental Coordination Disorder. Research in Developmental Disabilities.
doi:10.1016/j.ridd.2010.12.043
Kirk, R. E. (2003). The importance of effect magnitude. In S. F. Davis (Ed.). Handbook
of Research methods in Experimental Psychology (pp. 88-105). Malden, MA:
Blackwell Publishing.

62
Klimkeit, E. I., Sheppard, D. M., Lee, P., & Bradshaw, J. L. (2004). Bimanual
Coordination Deficits in Attention Deficit/Hyperactivity Disorder (ADHD).
Journal of Clinical & Experimental Neuropsychology, 26(8), 999-1010.
Konrad, K. & Eickhoff, S. B. (2010). Is the ADHD brain wired differently? A review on
structural and functional connectivity in Attention Deficit Hyperactivity Disorder.
Human Brain Mapping, 31, 904-916. doi: 10.1002/hbm.21058
Kushki, A., Schwellnus, H., Ilyas, F., & Chau, T. (2011). Changes in kinetics and
kinematics of handwriting during a prolonged writing task in children with and
without dysgraphia. Research in Developmental Disabilities, 32(3), 1058-1064.
doi:10.1016/j.ridd.2011.01.026
Lacquaniti, F. (1989). Central presentations of human limb movements as revealed by
studies of drawing and handwriting. Trends in Neurosciences, 12(8), 287-291.
doi:10.1016/0166-2236(89)90008-8
Lerer, R. J., Artner, J., & Lerer, M. (1979). Handwriting deficits in children with minimal
brain dysfunction: Effects of methylphenidate (Ritalin) and placebo. Journal of
Learning Disabilities, 12(7), 26. Retrieved from EBSCOhost.
Liston, C., Cohen, M. M., Teslovich, T., Levenson, D., & Casey, B. J. (2011). Atypical
prefrontal connectivity in Attention-Deficit/Hyperactivity Disorder: Pathway to
disease or pathological end point? Biological Psychiatry, 69, 1168-1177.
doi:10.1016/j.biopsych.2011.03.022
Mackie, S., Shaw, P., Lenroot, R., Pierson, R., Greenstein, D. K., Nugent, T. F., . . .
Rapoport, J. L. (2007). Cerebellar development and clinical outcome in Attention

63
Deficit Hyperactivity Disorder. The American Journal of Psychiatry, 164, 647655.
Mannuzza, S., Klein, R. G., Bessler, A., Malloy, P., & LaPadula, M. (1998). Adult
psychiatric status of hyperactive boys grown up. The American Journal Of
Psychiatry, 155, 493-498.
Margolin, D. I. & Wing, A. M. (1983). Agraphia and micrographia: Clinical
manifestations of motor programming and performance disorders. Acta
Psychologica, 54, 263-283. doi:10.1016/0001-6918(83)90039-2
Martin, N. C., Piek, J. P., & Hay, D. (2006). DCD and ADHD: A genetic study of their
shared aetiology. Human Movement Science, 25, 110-124.
doi:10.1016/j.humov.2005.10.006
McAlonan, G. M., Cheung, V., Cheung, C., Chua, S. E., Murphy, D. G. M., Suckling, J.,
. . . Ho, T. P. (2007). Mapping brain structure in attention deficit-hyperactivity
disorder: A voxel-based MRI study of regional gray and white matter volume.
Psychiatry Research: Neuroimaging, 154, 171-180.
doi:10.1016/j.pscychresns.2006.09.006
Mergl, R., Tigges, P., Schroter, A., Moller, H.-J., & Hegerl, U. (1999). Digitized analysis
of handwriting and drawing movements in healthy subjects: Methods, results, and
perspectives. Journal of Neuroscience Methods, 90, 157-169. doi:10.1016/S01650270(99)00080-1
Meulenbroek, R. G. J. & Thomassen, A. J. W. M. (1993). Exploitation of elasticity as a
biomechanical property in the production of graphic stroke sequences. Acta
Psychologica, 82(1-3), 313-327. doi:10.1016/0001-6918(93)90018-M

64
Meulenbroek, R. G. J. & van Galen, G. P. (1988). Foreperiod duration and the analysis of
motor stages in a line-drawing task. Acta Psychologica, 69, 19-34.
doi:10.1016/0001-6918(88)90027-3
Meyer, A & Sagvolden, T. (2006). Fine motor skills in South African children with
symptoms of ADHD: Influence of subtype, gender, age, and hand dominance.
Behavioral and Brain Functions, 2, 33. doi:10.1186/1744-9081-2-33
MovAlyzeR [Computer software]. Tempe, AZ: NeuroScript, LLC.
Narr, K. L., Woods, R. P., Lin, J., Kim, J., Phillips, O. R., Del’Homme, M., . . . Levitt, J.
G. (2009). Widespread cortical thinning is a robust anatomical marker for
Attention Deficit/Hyperactivity Disorder (ADHD). Journal of The American
Academy Of Child & Adolescent Psychiatry, 48, 1014-1022.
doi:10.1097/CHI.0b013e3181b395c0
Overvelde, A. & Hulstijn, W. (2011). Handwriting development in grade 2 and grade 3
primary school children with normal, at risk, and dysgraphic characteristics.
Research in Developmental Disabilities, 32, 540-548.
doi:10.1016/j.ridd.2010.12.027
Overvelde, A. & Hulstijn, W. (in press). Learning new movement patterns: A study on
good and poor writers comparing learning conditions emphasizing spatial, timing
or abstract characteristics. Human Movement Science.
doi:10.1016/j.humov.2010.08.016
Pereira, H. S., Eliasson, A.-C., & Forssberg, H. (2000). Detrimental neural control of
precision grip lifts in children with ADHD. Developmental Medicine & Child
Neurology, 42, 545-553.

65
Phillips, J. G., Bradshaw, J. L., Chiu, E. Teasdale, N., Iansek, R., & Bradshaw, J. A.
(1996). Bradykinesia and movement precision in Huntington’s disease.
Neuropsychologia, 34, 1241-1245. doi:10.1016/0028-3932(96)00049-8
Phillips, J. G., Chiu, E., Bradshaw, J. L., & Iansek, R. (1995). Impaired movement
sequencing in patients with Huntington’s disease: A kinematic analysis.
Neuropsychologia, 33, 365-369. doi:10.1016/0028-3932(94)00114-5
Phillips, J. G., Ogeil, R. P., & Muller, F. (2009). Alcohol consumption and handwriting:
A kinematic analysis. Human Movement Science, 28, 619-632.
doi:10.1016/j.humov.2009.01.006
Piek, J. P., Pitcher, T. M., & Hay, D. A. (1999). Motor coordination and kinaesthesis in
boys with attention deficit-hyperactivity disorder. Developmental Medicine &
Child Neurology, 41, 159-165. doi:10.1017/S0012162299000341
Pitcher, T. M., Piek, J. P., & Barrett, N. C. (2002). Timing and force control in boys with
Attention Deficit Hyperactivity Disorder: Subtype differences and the effect of
comorbid developmental coordination disorder. Human Movement Science, 21,
919-945. doi:10.1016/S0167-9457(02)00167-7
Plamondon, R. (1993). Looking at handwriting generation from a velocity control
perspective. Acta Psychologica, 82, 89-101. doi:10.1016/0001-6918(93)90006-D
Plamondon, R. (1995a). A kinematic theory of rapid human movements. Part I:
Movement representation and generation. Biological Cybernetics, 72, 295-307.
doi:10.1007/BF00202785

66
Plamondon, R. (1995b). A kinematic theory of rapid human movements: Part II:
Movement time and control. Biological Cybernetics, 73, 309-320.
doi:10.1007/BF00199060
Plamondon, R. (1998). A kinematic theory of rapid human movements: Part III: Kinetic
outcomes. Biological Cybernetics, 78, 133-145. doi:10.1007/s004220050420
Plamondon, R., Feng, C., & Woch, A. (2003). A kinematic theory of rapid human
movement. Part IV: A formal mathematical proof and new insights. Biological
Cybernetics, 89, 126-138. doi:10.1007/s00422-003-0407-9
Plamondon, R. & Maarse, F. J. (1989). An evaluation of motor models of handwriting.
Systems, Man, and Cybernetics, 19, 1060-1072. doi:10.1109/21.44021
Plamondon, R., Yu, L., Stelmach, G. E., & Clement, B. (1991). On the automatic
extraction of biomechanical information from handwriting signals. Systems, Man,
and Cybernetics, 21, 90-101. doi:10.1109/21.101140
Poluha, P. C., Teulings, H.-L., & Brookshire, R. H. (1998). Handwriting and speech
changes across the levodopa cycle in Parkinson’s disease. Acta Psychologica,
100, 71-84. doi:10.1016/S0001-6918(98)00026-2
Ponsen, M. M., Daffertshofer, A., van den Heuvel, E., Wolters, E. Ch., Beek, P. J., &
Berendse, H. W. (2006). Bimanual coordination dysfunction in early, untreated
Parkinson’s disease. Parkinsonism & Related Disorders, 12, 246-252.
doi:10.1016/j.parkreldis.2006.01.006
Portier, S. J. & van Galen, G. R. (1992). Immediate vs. postponed visual feedback in
practicing a handwriting task. Human Movement Science, 11, 563-592.
doi:10.1016/0167-9457(92)90016-5

67
Posner, J., Maia, T. V., Fair, D., Peterson, B. S., Sonuga-Barke, E. J., & Nagel, B. J.
(2011). The attenuation of dysfunctional emotional processing with stimulant
medication: An fMRI study of adolescents with ADHD. Psychiatry Research:
Neuroimaging, 193, 151-160. doi:10.1016/j.pscychresns.2011.02.005
Putzhammer, A., Perfahl, M., Pfeiff, L., Ilbach, B., Johann, M., Zitzelsberger, U., &
Hajak, G. (2005). Performance of diadochokinetic movements in schizophrenic
patients. Schizophrenia Research, 79, 271-280. doi:10.1016/j.schres.2005.05.020
Rand, M. K., Stelmach, G. E., & Bloedel, J. R. (2000). Movement accuracy constraints in
Parkinson’s disease patients. Neuropsychologia, 38, 203-212.
Romanos, M., Weise, D., Schliesser, M., Schecklmann, M., Loffler, J., Warnke, A., . . .
Mehler-Wex, C. (2010). Structural abnormality of the substantia nigra in children
with attention-deficit hyperactivity disorder. Journal of Psychiatry Neuroscience,
35, 55-58. doi:10.1503/jpn.090044
Rommelse, N. J., Altink, M. E., Fliers, E. A., Martin, N. C., Buschgens, C. M., Hartman,
C. A., . . . Oosterlaan, J. (2009). Comorbid problems in ADHD: Degree of
association, shared endophenotypes, and formation of distinct subtypes.
Implications for a future DSM. Journal of Abnormal Child Psychology: An
official publication of the International Society for Research in Child and
Adolescent Psychopathology, 37, 793-804. doi:10.1007/s10802-009-9312-6
Rommelse, N. N. J., Altink, M. E., Oosterlaan, J., Beem, L., Buschgens, C. J. M.,
Buitelaar, J., & Sergeant, J. A. (2008). Speed, variability, and timing of motor
output in ADHD: Which measures are useful for endophenotypic research?
Behavior Genetics, 38, 121-132. doi: 10.1007/s10519-007-9186-8

68
Root, R., & Resnick, R. J. (2003). An update on the diagnosis and treatment of attentiondeficit/hyperactivity disorder in children. Professional Psychology: Research and
Practice, 34, 34-41. doi:10.1037/0735-7028.34.1.34
Rosenblum, S., Dvorkin, A. Y., & Weiss, P. L. (2006). Automatic segmentation as a tool
for examining the handwriting process of children with dysgraphic and proficient
handwriting. Human Movement Science, 25, 608-621.
doi:10.1016/j.humov.2006.07.005
Rosenblum, S., Epsztein, L., & Josman, N. (2008). Handwriting performance of children
with Attention Deficit Hyperactive Disorders: A pilot study. Physical &
Occupational Therapy in Pediatrics, 28, 219-234.
Rosenblum, S. & Livneh-Zirinski, M. (2008). Handwriting process and product
characteristics of children diagnosed with developmental coordination disorder.
Human Movement Science, 27, 200-214. doi:10.1016/j.humov.2008.02.011
Rubia, K., Overmeyer, S., Taylor, E., Brammer, M., Williams, S. R., Simmons, A., &
Bullmore, E. T. (1999). Hypofrontality in attention deficit hyperactivity disorder
during higher-order motor control: A study with functional MRI. The American
Journal of Psychiatry, 156, 891-896.
Sattler, J. M. & Ryan, J. J. (2009). Assessment with the WAIS-IV. La Mesa, CA: Sattler.
Schroter, A., Mergl, R., Burger, K., Hampel, H., Moller, H.-J., & Hegerl, U. (2003).
Kinematic analysis of handwriting movements in patients with Alzheimer’s
Disease, Mild Cognitive Impairment, Depression and Healthy subjects. Dementia
and Geriatric Cognitive Disorders, 15, 132-142. doi:10.1159/000068484

69
Seidman, L. J., Biederman, J., Liang, L., Valera, E. M., Monuteaux, M. C., Brown, A., . .
. Makris, N. (2011). Gray matter alternations in adults with AttentionDeficit/Hyperactivity Disorder identivied by voxel based morphometry.
Biological Psychiatry, 69, 857-866. doi:10.1016/j.biopsych.2010.09.053
Seidman, L. J., Valera, E. M., Makris, N., Monuteaux, M. C., Boriel, D. L., Kelkar, K., . .
. Biederman, J. (2006). Dorsolateral prefrontal and anterior cingulated cortex
volumetric abnormalities in adults with Attention-Deficit/Hyperactivity Disorder
identified by magnetic resonance imaging. Biological Psychiatry, 60, 1071-1080.
doi:10.1016/j.biopsych.2006.04.031
Semrud-Clikeman, M., Filipek, P. A., Biederman, J., & Steingard, R. (1994). Attentiondeficit hyperactivity disorder: Magnetic resonance imaging morphometric
analysis of the corpus callosum. Journal Of The American Academy Of Child &
Adolescent Psychiatry, 33, 875-881. doi:10.1097/00004583-199407000-00014
Shafritz, K. M., Marchione, K. E., Gore, J. C., Shaywitz, S. E., & Shaywitz, B. A. (2004).
The effects of methylphenidate on neural systems of attention in attention deficit
hyperactivity disorder. American Journal of Psychiatry, 161, 1990-1997.
Shaw, P., Lerch, J., Greenstein, D., Sharp, W., Clasen, L., Evans, A., . . . Rapoport, J.
(2006). Longitudinal mapping of cortical thickness and clinical outcome in
children and adolescents with Attention-Deficit/Hyperactivity Disorder. Archives
of General Psychiatry, 63, 540-549. doi:10.1001/archpsyc.63.5.540
Slavin, M. J., Phillips, J. G., Bradshaw, J. L., Hall, K. A., & Presnell, I. (1999).
Consistency of handwriting movements in dementia of the Alzheimer's type: A
comparison with Huntington's and Parkinson's diseases. Journal of the

70
International Neuropsychological Society, 5(1), 20-25.
doi:10.1017/S135561779951103X
Smits-Engelsman, B. C. M., Niemeijer, A. S., & van Galen G. P. (2001). Fine motor
deficiencies in children diagnosed as DCD based on poor grapho-motor ability.
Human Movement Science, 20, 161-182. doi:10.1016/S0167-9457(01)00033-1
Smits-Engelsman, B. C. M. & van Galen, G. P. (1997). Dysgraphia in children: Lasting
psychomotor deficiency or transient developmental delay? Journal of
Experimental Child Psychology, 67, 164-184. doi:10.1006/jecp.1997.2400
Stevens, J. P. (2009). Applied multivariate statistics for the social sciences (5th ed.). New
York, NY: Routledge.
Stray, L. L., Stray, T., Iversen, S., Ruud, A., & Ellertsen, B. (2009). Methyophenidate
improves motor functions in children diagnosed with Hyperkinetic Disorder.
Behavioral and Brain Functions, 5, 21. doi:10.1186/1744-9081-5-21.
Swanson, J., Castellanos, F. X., Murias, M. LaHoste, G. & Kennedy, J. (1998). Cognitive
neuroscience of Attention Deficit Hyperactivity Disorder and Hyperkinetic
Disorder. Current Opinion in Neurobiology, 8, 263-271.
Teicher, M. H., Anderson, C. M., Polcari, A., Glod, C. A., Maas, L. C., & Renshaw, P. F.
(2000). Functional deficits in basal ganglia of children with attentiondeficit/hyperactivity disorder shown with functional magnetic resonance imaging
relaxometry. Nature Medicine, 6, 470-473.
Teulings, H.-L., Contreras-Vidal, J. L., Stelmach, G. E., & Adler, C. H. (1997).
Parkinsonism reduces coordination of fingers, wrist, and arm in fine motor control
Experimental Neurology, 146(1), 159-170. doi:10.1006/exnr.1997.6507

71
Teulings, H., Thomassen, A. J., & Van Galen, G. P. (1983). Preparation of partly precued
handwriting movements: The size of movement units in handwriting. Acta
Psychologica, 54(1-3), 165-177. doi:10.1016/0001-6918(83)90031-8
Tigges, P., Mergl, R., Frodl, T., Meisenzahl, E. M., Gallinat, J., Schroter, A., . . . Hegerl,
U. (2000). Digitized analysis of abnormal hand-motor performance in
schizophrenic patients. Schizophrenia Research, 45, 133-143. doi:10.1016/S09209964(99)00185-1
Tucha, O. & Lange, K. W. (2001). Effects of methylphenidate on kinematic aspects of
handwriting in hyperactive boys. Journal of Abnormal Child Psychology, 29, 351356.
Tucha, O. & Lange, K. (2004). Handwriting and attention in children and adults with
Attention Deficit Hyperactivity Disorder. Motor Control, 8, 461-471.
Tucha, O. & Lange, K. (2005). The effect of conscious control on handwriting in children
with Attention Deficit Hyperactivity Disorder. Journal of Attention Disorders, 9,
323-332.
Tucha, O., Mecklinger, L., Laufkotter, R., Klein, H. E., Walitza, S., & Lange, K. W.
(2006). Methylphenidate-induced improvements of various measures of attention
in adults with Attention Deficit Hyperactivity Disorder. Journal of Neural
Transmission, 113(10), 1575-1592. doi:10.1007/s00702-005-0437-7
Tucha, O., Mecklinger, J. T., Reiter, A., Alders, G. L., Sartor, H., Naumann, M., &
Lange, K. W. (2006). Kinematic analysis of dopaminergic effects on skilled
handwriting movements in Parkinson’s disease. Journal of Neural Transmission,
113, 609-623. doi:10.1007/s00702-005-0346-9

72
Tucha, O., Mecklinger, L., Walitza, S., & Lange, K. W. (2006). Attention and movement
execution during handwriting. Human Movement Science, 25, 536-552.
doi:10.1016/j.humov.2006.06.002
Tucha, O., Paul, G. M., & Lange, K. W. (2003). Attentional control of handwriting
movements. The International Journal of Forensic Document Examiners, 6, 1-4.
Tucha, O., Prell, S., Mecklinger, L., Bormann-Kischkel, C., Kubber, S., Linder, M., . . .
Lange, K. W. (2006). Effects of methylphenidate on multiple components of
attention in children with Attention Deficit Hyperactivity Disorder.
Psychopharmacology, 185, 315-326. doi:10.1007/s00213-006-0318-2
U. S. Food and Drug Administration. FDA Asks Attention-Deficit Hyperactivity
Disorder (ADHD) Drug Manufacturers to Develop Patient Medication Guides.
Retrieved from
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatie
ntsandProviders/ucm107918.htm
Vaidya, C. J., Austin, G., Kirkorian, G., Ridlehuber, H. W., Desmond, J. E., Glover, G.
H., & Gabrieli, G. (1998). Selective effects of methylphenidate in attention deficit
hyperactivity disorder: A functional magnetic resonance study. Proceedings of the
National Academy of Sciences of the United States of America, 95, 14494-14499.
doi: 10.1073/pnas.95.24.14494
van Galen, G. P. (1990). Phonological and motoric demands in handwriting: Evidence for
discrete transmission of information. Acta Psychologica, 74(2-3), 259-275.
doi:10.1016/0001-6918(90)90008-4

73
van Galen, G. P. (1991). Handwriting: Issues for a psychomotor theory. Human
Movement Science, 10, 165-191. doi:10.1016/0167-9457(91)90003-G
van Galen, G. P., Portier, S. J., Smits-Engelsman, B. C. M., & Schomaker, L. R. B.
(1993). Neuromotor noise and poor handwriting in children. Acta Psychologica,
82(1-3), 161-178. doi:10.1016/0001-6918(93)90010-O
van Gemmert, A. W. A., Teulings, H.-L., & Stelmach, G. E. (1998). The influence of
mental and motor load on handwriting movements in Parkinsonian patients. Acta
Psychologica, 100, 161-175. doi:10.1016/S0001-6918(98)00032-8
van Roon, D., Caeyenberghs, K., Swinnen, S. P., & Smits-Engelsman, B. C. M. (2010).
Children with a learning disorder show prospective control impairments during
visuomanual tracking. Research in Developmental Disabilities, 31, 195-202.
doi:10.1016/j.ridd.2009.09.004
Viviani, P. & Terzuolo, C. (1982). Trajectory determines movement dynamics.
Neuroscience, 7, 431-437. doi:10.1016/0306-4522(82)90277-9
Wann, J. & Nimmo-Smith, I. (1991). The control of pen pressure in handwriting: A
subtle point. Human Movement Science, 10, 223-246. doi:10.1016/01679457(91)90005-I
Wechsler, D. (2008). Wechsler Adult Intelligence Scale–Fourth Edition. San Antonio,
TX: Pearson.
Whalen, C. K., Henker, B., & Finck, D. (1981). Medication effects in the classroom:
Three naturalistic indicators. Journal of Abnormal Child Psychology: An Official
Publication of The International Society For Research In Child And Adolescent
Psychopathology, 9, 419-433. doi:10.1007/BF00917793

74
Woch, A., Plamondon, R., & O’Reilly, C. (2011). Kinematic characteristics of
bidirectional delta-lognormal primitives in young and older subjects. Human
Movement Science, 30(1), 1-17.
Yaguez, L., Canavan, A. G. M., Lange, H. W., & Homberg, V. (1999). Motor learning by
imagery is differentially affected in Parkinson’s and Huntington’s diseases.
Behavioural Brain Research, 102, 115-127. doi:10.1016/S0166-4328(99)00005-4
Yan, J. H., Rountree, S., Massman, P., Doody, R. S., & Li, H. (2008). Alzheimer’s
disease and mild cognitive impairment deteriorate fine movement control. Journal
of Psychiatric Research, 42, 1203-1212. doi:10.1016/j.jpsychires.2008.01.006
Yeo, R. A., Hill, D. E., Campbell, R. A., Vigil, J., Petropoulos, H., Hart, B., & ... Brooks,
W. M. (2003). Proton magnetic resonance spectroscopy investigation of the right
frontal lobe in children with attention-deficit/hyperactivity disorder. Journal Of
The American Academy Of Child & Adolescent Psychiatry, 42, 303-310.
doi:10.1097/00004583-200303000-00010

VITA AUCTORIS
The author, Thomas A. Duda, was born in Detroit, Michigan in January, 1977. He
graduated from Algonac High School in 1995 and subsequently achieved a Bachelor of
Business Administration in Accounting with Honors (Magna Cum Laude) from Baker
College of Port Huron in 2000. After working in the telecommunications industry as a
facility manager, systems analyst, and project manager for eight years, he returned to
academic training to pursue a career in Neuropsychology and in turn obtained a Bachelor
of Science in Research Psychology (Cognitive Science) with High Honors from the
University of Michigan-Flint. The author was then accepted to the University of Windsor
in 2010 where he later earned a Masters of Arts degree in Clinical Neuropsychology in
2012. During this time, he has conducted or contributed to research that has resulted in
poster presentations at the 2012 National Academy of Neuropsychology Conference in
Nashville, Tennessee; the 2010 Conference on Human Development in New York, New
York; the 2010 Annual Meeting for the Child Neurology Society in Louisville, Kentucky;
and the 2009 Meeting of Minds XVII Undergraduate Research Conference in Dearborn,
Michigan.

75

